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ABSTRACT 
 
Non-covalent interactions, especially those involving arenes, perform critical 
roles in biological processes, including ligand-protein and ligand-nucleic acid 
interactions, as well as protein and DNA/RNA stability and function. We investigated 
non-covalent interactions involving aromatic rings using computational chemistry in 
four contexts: sequence-selective DNA-binding antibodies, nitroarene-protein 
interactions, heterocycle-adenine interactions, and the tuning of amino acid pKa’s. We 
first surveyed recent advances in our understanding of alkali metal cation-π interactions 
and their role in both experimental and theoretical fields. Then quantum mechanical 
computations and classical molecular mechanics based molecular dynamics simulations 
were utilized as the main tools to explore non-covalent interactions involving π-system 
in biological systems.  
We present computational analyses of the binding of four dinucleotides to a 
sequence-selective single-stranded DNA (ssDNA) binding antibody (ED-10) and 
selected point-mutants using MMGBSA as well as DFT applied to a cluster model of the 
binding site. The results indicate that the sequence selectivity arises primarily from 
differences in the strength of π-stacking and XH/π interactions with the surrounding 
aromatic residues; hydrogen bonds play little role.  
Stacking interactions in nitroarene binding sites of proteins were studied through 
analyses of structures in the protein data bank (PDB), as well as DFT and ab initio 
computations applied to model systems. The results show that the interactions between 
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aromatic amino acids and nitroarenes are very strong, and the regiochemistry of the nitro 
substituents plays a significant role in the relative monomer orientations and strength of 
the interaction.  
Next, complexes of 9-methyladenine with 46 heterocycles commonly found in 
drugs were studied using dispersion-corrected density function theory, revealing 268 
unique stacked dimers. The predicted binding energies for each heterocycle span a broad 
range, highlighting the strong dependence of heterocycle stacking interactions on the 
relative orientation of the two arenes. The data reveal several key local, direct 
interactions that strongly influence the preferred orientation and strength of the most 
favorable stacked complexes.  
Finally, the impact of π-stacking interactions on the pKa of ionizable amino acid 
side chains was investigated by DFT computations. π-stacking interactions, edge-to-face 
interactions, CH/π interactions, and NH/π interactions abound in these complexes, and 
impact the acidity of these ionizable groups.  
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CHAPTER I 
INTRODUCTION AND BACKGROUND 
 
Nature of Non-covalent Interaction 
Macromolecular structure is determined and maintained by a combination of 
covalent and non-covalent interactions. Non-covalent interactions occur through a 
variety of mechanisms, including electrostatic, van der Walls, hydrogen bonding, and 
hydrophobic interactions. Electrostatic interactions, in the narrow sense, are the 
Coulombic interactions between charged species. Van der Waals interactions are weak 
interactions that occur between all molecules, and are dominated by London dispersion 
forces. These result from the interaction between instantaneous dipoles formed via 
transient distortion of electron clouds within a molecule. Molecules also interact with 
each other through interactions of permanent dipoles and dipole induced-dipole 
interactions. Finally, hydrogen bonds are formed between a hydrogen atom attached to 
an electronegative donor atom and a neighboring acceptor atom. Hydrogen bonding is a 
relatively strong and directional non-covalent interaction, with its magnitude and 
directionality determined primarily by the electrostatic forces between the donor 
hydrogen atom and the acceptor atom. 
In this research, we focus on the impact of π-stacking and XH/π interactions on 
various biological systems. At the supramolecular level, aromatic rings can interact in 
three prototypical configurations: stacked, edge-to-face, and T-shaped (see Figure I-1). 
The non-covalent interaction we are primarily interested in is the π–stacking interaction. 
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Although on average π–stacking interactions are weaker than hydrogen bonding, π–
stacking interactions play a critical role in many self-assembly and molecular 
recognition processes. XH/π interactions, in which the hydrogen of a NH or CH group is 
directed toward the face of an aromatic ring, also make important contributions to 
biomolecular structure and function. These weakly polar interactions can also play 
essential roles in macromolecular function. XH/π interactions are best classified 
somewhere between conventional hydrogen bonds and weaker interactions dominated by 
dispersion, and are dependent on the orientation of the donor and acceptor group. 
London dispersion interactions, which occur between all molecules, are attractive 
non-covalent interactions arising from instantaneous polarization due to unequal 
distributions of electrons. In general, the strength of dispersion interaction increases with 
molecular size, because larger molecules tend to have larger polarizabilities. For 
nonpolar molecules, dispersion is the dominant non-covalent interaction, much stronger 
than other Van der Waals forces. In this research, the significance of dispersion 
interaction will be discussed thoroughly, since aromatic systems in biological 
environment are quite nonpolar.  
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Figure I-1. Model aromatic interactions showing a. stacking, b. edge-to-face, c. T-
shaped configurations. 
 
 
Non-covalent Interaction with Aromatic Rings in Biology  
Non-covalent interactions involving aromatic rings are critical for organization 
and assembly in supramolecular and biological chemistry.
1,2
 They are indispensable for 
proteins and nucleic acids to adopt their correct three dimensional configurations and 
perform their functions.
3
 These non-covalent forces also play a significant role in 
protein-DNA interactions, protein-ligand interactions, nucleic acid-ligand interactions, 
and interactions between amino acids both within a given protein and in protein-protein 
interactions.  
Protein-DNA interactions participate in a variety of key biological processes, 
such as DNA replication, transcription, translation, and control of gene expression. For 
instance, proteins can bind both single-stranded DNA and double-stranded DNA,
4-7
 and 
many DNA-binding antibodies show sequence-specific recognition dependent on 
various non-covalent interactions. Exploring non-covalent interactions between antibody 
and DNA and elucidating the general mechanism of base selectivity at the molecular 
level is crucial to further understanding mechanism of many auto-immune diseases.  
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Protein–ligand interactions are also vitally important in biological processes, 
including molecular recognition, conformational stability, signal transmission, regulation 
of enzyme activity, and regulation of gene replication.
8
 Detailed structural analyses at 
the atomic level reveal that non-covalent interactions central for the binding of ligands 
by proteins.
9,10
 Thus, understanding protein–ligand binding affinities, especially for 
drug-like small molecules, is central to pharmaceutical design.
11
 Since computational 
approaches have become an essential part of the drug discovery process,
12,13
 accurate 
computations of non-covalent interactions in biological contexts and detailed analyses of 
ligand binding sites are fundamentally important in medicinal chemistry.  
A large number of therapeutic agents with antitumor, antibacterial, and antiviral 
activities perform their functions through noncovalent interaction between nucleic acids 
(both DNA and RNA) and small molecules.
14
 For instance, DNA intercalating antitumor 
agents, such as distamycin, berenil, and actinomycin, bind the minor groove of double-
stranded oligodeoxynucleotides non-covalently.
15
 Sundry RNA molecules, including 
ribosomal RNA, tRNA, trans-activating response RNA, and rev response element RNA, 
are antibacterial and antiviral drug targets.
16-18
 Thus, elucidating the specific mechanism 
of non-covalent interaction between small molecule and DNA/RNA is beneficial for 
rational drug design. 
Finally, non-covalent interactions with aromatic amino acids are fundamentally 
crucial in protein stability and function.
19-23
 For instance, π-stacking interactions may 
play a vital role in the molecular recognition and formation of  amyloid fibrils self-
assembly.
24
 Aromatic residues not only engage in π-stacking interactions but also other 
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non-covalent interactions with aromatic amino acids.
25,26
 For example, XH/π interactions 
are present in many dimers of aromatic amino acids. Although such interactions are 
ubiquitous in protein crystal structures,
27-30
 their origin and significance in biomolecular 
process is still largely unsettled. A thorough understanding of how aromatic residues 
interact with nearby amino acids, and how XH/π interactions are involved, will shed 
light on our knowledge about protein-protein interaction. 
 
Computational Chemistry Methods in Biology  
Computational chemistry is a branch of chemistry that applies mathematical 
algorithms and statistical theories based on either classical- or quantum-mechanical 
treatment of molecular systems in order to determine the various properties of a 
chemical system, particularly the structure and energy of the species.
31,32
 Modern 
computational chemistry finds increasing applications in areas spanning from chemical 
catalysis, novel material design, molecular spectroscopy, to solid-state chemistry, 
enzymatic reactions, and drug discovery, etc.
33-42
 
One major field of computational chemistry is molecular mechanics (MM), 
which utilizes classical mechanics to model (typically large) molecules. In such 
simulations, the atoms are treated as masses and bonds treated as springs with 
empirically-determined force constants. The force-constants for all relevant bends, 
angles, dihedral angles, and non-covalent interactions between atoms (Lennard-Jones 
and Coulombic Interactions) are incorporated into a fixed functional form to find the 
potential energy of the system.
43-45 
These force constants are optimized to fit 
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experimental results or highly accurate quantum mechanical computations. As the force 
field is built from such empirical parameters, calculations using force field methods are 
in general less accurate but faster compared to quantum mechanical calculations. 
Therefore, force field techniques are mainly applied in large systems where tens of 
thousands of atoms/molecules are involved, such as proteins, polymers, and other 
organic/inorganic materials.
46
 
Based on molecular mechanics, molecular dynamics (MD) is the computational 
technique to simulate the classical motion of atoms as a function of time.
47,48
 In MD 
simulations, trajectories are computed by numerically solving Newton equations of 
motion based on the forces given by the empirical force field. In biological systems, 
molecular dynamics simulation finds excellent applications in areas like protein and 
RNA folding pathways, binding modes and energies between ligand and protein/nucleic 
acid, and solvation free energies of biological macromolecules, etc.
13,49-53
  
The concept of free energy is fundamental to chemistry, as free energy changes 
of molecular systems define their tendencies to associate and react. Therefore, being able 
to accurately predict the free energy change in various biological processes using MD 
simulation is advantageous. The main types of free energy computations applied to 
biological systems are solvation/transfer free energy, conformational free energy, and 
binding free energy. The two most conventional schemes to calculate free energy in 
biological context are thermodynamic integration and free energy perturbation theory.
54-
56
 Both methods rely on statistical mechanics and thermodynamic cycles to calculate the 
free energy difference between two end-states based on a series of (possibly fictitious) 
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intermediate states. In practice these two methods are very computationally expensive 
because the process of free energy change has to be divided into a sufficient number of 
simulation “windows” and the ensemble average needs to be evaluated for each of these 
windows. Alternative approaches that are less computational costly are “end-state 
methods”. For a macromolecule-ligand complex, the binding free energy is defined as 
 ∆𝐺 = 𝐺𝑐𝑜𝑚𝑝𝑙𝑒𝑥 − 𝐺𝑚𝑎𝑐𝑟𝑜𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒 − 𝐺𝑙𝑖𝑔𝑎𝑛𝑑 (I-1) 
MM-PBSA is a popular end-state method focusing on implicit solvent models, 
where MM means this method is based on molecular mechanics, PB refers to the fact 
that in the original method the electrostatic energy was evaluated by Poisson–Boltzmann 
model, and SA means the surface area is used to calculate the non-polar energy in 
solution.
57
 MM-GBSA is based on ensembles derived from molecular dynamics or 
Monte Carlo simulations. The MM-PBSA method integrated in the AMBER package
58
 
provides a variety of implicit solvent models, including the Poisson–Boltzmann, the 
Generalized Born, and the Reference Interaction Site models.
59
 For more rigorous 
results, contributions to the entropy from solute vibrations may be computed using 
normal mode or quasi-harmonic analysis.  
Accuracy is still a challenge for force field methods built on empirical 
parameters. For highly accurate results, quantum mechanical computations based on 
(approximately) solving the Schrödinger equation are necessary. The Schrödinger 
equation describes quantum mechanical behavior of physical systems, where the 
wavefunction defines the quantum state of the system. The wavefunction contains all 
information about the system but it does not have classical physical significance. The 
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square of the wave function has physical significance as a probability density. The time-
dependent Schrödinger equation describes how the wavefunction changes with time, 
 𝑖ℏ
𝜕
𝜕𝑡
Ψ(𝑟, 𝑡) = ?̂?Ψ(𝑟, 𝑡) (I-2) 
where Ψ(𝑟, 𝑡) is the wavefunction and ?̂? is the Hamiltonian (total energy) operator. In 
this research we only focus on time-independent Schrödinger equation, which is the 
more commonly used form for computations in chemical and biological context. The 
general form of time-independent Schrödinger equation is: 
 [
̶ ћ2
2𝜇
∇2 + V(r)] Ψ(𝑟) = 𝐸Ψ(𝑟) (I-3) 
where V(r) is the potential energy and Ψ(𝑟) is the (time-independent) stationary state 
wavefunction. For systems with more than one electron, the Schrödinger equation cannot 
be solved analytically due to electron-electron interactions. Therefore, approximations 
have to be made to get desired wave functions and energies of the system.  
In ab initio electronic structure methods, the electronic wavefunction is 
expressed as one or more anti-symmetrized linear combination of molecular orbitals 
(Slater determinants). These molecular orbitals are expressed as a linear combination of 
atom-centered Gaussian basis functions (the basis set).
60
 In Hartree-Fock (HF) theory, 
the wavefunction is represented by a single Slater determinant, with the underlying 
molecular orbitals derived by minimizing the quantum mechanical energy (the 
variational method). In Hartree-Fock theory, each electron is treated as if it is subjected 
to the repulsion of the mean field of all of the other electrons. A variety of post-HF ab 
initio methods are designed to improve upon the Hartree-Fock energy and wavefunction 
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by incorporating the effects of other Slater determinants. Common post Hartree-Fock 
methods include configuration interaction, coupled cluster, and Møller–Plesset 
perturbation theory methods. As the number of determinants and size of the basis set size 
are increased, these approach the exact solution of the non-relativistic Schrödinger 
equation. Unfortunately, this comes with a sharp increase in computational cost. 
Density functional theory (DFT), initially developed by physicists to solve solid-
state and condensed phase problems, has recently become the major computational tool 
for electronic structure problems due to its excellent performances in balancing accuracy 
and computational cost.
33,61,62
 A functional is a function that acts on another function to 
give a scalar. Unlike ab initio methods, in DFT the energy of a many-electron system are 
computed from electron density, ρ(r), rather than the full many-dimensional 
wavefunction. As a result, DFT is computationally much less expensive compared to ab 
initio methods, but modern DFT methods can provide accuracy rivaling that of many ab 
initio methods. In particular, DFT computations scale as N
3
 to N
4
, where N is the size of 
the system, whereas ab initio methods scales as N
4
 in the best case (Hartree-Fock), or 
worse for more accurate ab initio methods. The Hohenberg-Kohn (HK) theorems laid the 
theoretical foundation for modern DFT.
63
 The first HK theorem states that the exact 
energy of a quantum mechanical system (under the Born-Oppenheimer approximation) 
can be determined by a universal functional of the exact density, ρ(r). The second HK 
theorem states that when this universal functional is applied to an approximate electron 
density, the resulting energy is an upper bound to the exact energy. Unfortunately, the 
form of this universal functional is unknown. 
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  Kohn and Sham introduced orbitals into density functional theory.
64
 In the 
Kohn-Sham approach, a fictitious system of non-interacting electrons is constructed to 
generate the same density as the true system. Since the system only consists of non-
interacting electrons, the wave function can be expressed as a single Slater determinant 
constructed from molecular orbitals. In the Kohn-Sham energy expression, the total 
energy is given by 
 𝐸[ρ(r)] = 𝑇𝑠[ρ(r)] + 𝑉𝑛𝑒[ρ(r)] + 𝐽[ρ(r)] + 𝐸𝑥𝑐[ρ(r)] (I-4) 
where the terms are, from left to right, the kinetic energy of the non-interacting 
electrons, the Coulombic attraction of the electrons to the nuclei, the Coulombic 
interaction of the electrons, and the exchange-correlation energy.  
The exchange-correlation energy is where the KS energy expression differs from 
Hartree-Fock, and is the only component of this energy for which an exact expression is 
not known. The exchange effect was discovered by Heisenberg and Dirac separately,
65,66
 
and result from the fact that wave function of indistinguishable electrons must change 
sign when the coordinates of two electrons are exchanged. The correlation energy arises 
from the correlated motion of interacting electrons, which is conventionally defined as 
the difference between the exact energy and Hartree-Fock energy. Typical exchange-
correlation energy expressions are split into separate components to describe these two 
effects. Together, the exchange functional and correlation functional define a given DFT 
functional. There are many popular DFT functionals that provide reliable molecular 
structures and energies. Unfortunately, many standard DFT functionals fail to describe 
dispersion interactions. However, there has been tremendous progress the last few years 
 11 
 
developing DFT methods that capture dispersion interactions.
67
 The simplest approach is 
the DFT-D method, in which an empirical dispersion term is simply added to the energy 
from a conventional DFT functional.
68,69
 Examples of DFT-D functionals include B97-D 
and B3LYP-D3. We will use the former method, which provides reliable predictions of 
π-stacking, CH/π, and other non-covalent interactions, almost exclusively in this work.  
 12 
 
CHAPTER II  
ALKALI METAL CATION-Π INTERACTIONS* 
 
Introduction 
Cation−π interactions, in which positively-charged atomic or polyatomic ions 
interact with the faces of aromatic rings (see Figure II-1), are prevalent in chemical 
systems, playing vital roles in the fields of chemistry, materials science, biology, and 
allied areas.
70-72
 Although these interactions were only recognized a few decades ago,
73-
75
 their significance and importance has been firmly established in recent years. 
Cation−π interactions are primarily electrostatic in origin, arising from the interaction of 
a cation with the negatively charged π-electron cloud of an arene, and are often among 
the strongest non-covalent interactions. However, under some circumstances, cation−π 
interactions may also be relatively weak, depending on the nature of the cation and the 
arene. Indeed, the strength of cation–π interactions can be tuned over a surprisingly large 
range, and it is this variability that underlies the utility of cation–π interactions in many 
contexts. It also leads to challenges quantifying their role in many chemical systems. 
Overall, understanding the nature, strength, and relevance of cation−π interactions is of 
paramount importance in the design of functional molecules and materials.  
 
                                                 
*
 Reprinted with permission from “Cation-π Interactions” by Y. An and S. E. Wheeler, 2015. The Lightest 
Metals: Science and Technology from Lithium to Calcium, T. Hanusa (Ed) 173, Copyright © 2015 John 
Wiley & Sons Inc. 
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Figure II-1. Prototypical cation–π interactions of alkali metal cations with benzene. 
Optimized distances above the ring center and gas-phase interaction energies (Eint, in 
kcal mol
–1
) are based on high-accuracy gas-phase computations from Sherrill and co-
workers.
76
 
 
 
There have been a number of reviews of cation–π interactions in recent years,73-
75,77,78
 including the seminal work of Ma and Dougherty
73
 and more recent reviews from 
Dougherty
74
 and by Mahadevi and Sastry.
75
 Although cation–π interactions often involve 
polyatomic cations, most notably quaternary ammoniums, in this chapter we focus on 
cation−π interactions involving the alkali metal cations Li+, Na+, and K+. Complexes 
involving these simple cations have long served as models for more general cation–π 
interactions, and also play key roles in many areas of chemistry. Here, we survey their 
roles in chemistry, biology, and materials science, with particular attention paid to 
understanding the factors responsible for modulating the strength of cation−π 
interactions, along with their structural and functional significance. 
 
Nature of Cation–π Interactions 
Cation−π interactions result from the interaction of a closed shell cation with a 
neutral π-system.79,80 Although this moniker was initially used to refer to the interaction 
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of a cation with either aromatic or non-aromatic π-systems, popular use in recent years 
has centered on interactions with arenes. Consequently, such interactions will be the 
focus here. Cation–π interactions have a rich history spanning the last three decades, and 
our understanding of the nature of these interactions has continued to evolve over this 
time.
70-72
 
The Genesis of Cation–π Interactions 
The history of cation–π interactions begins in the early 1980s, when Kebarle and 
co-workers reported
81
 the first measurements of K
+
 interacting with benzene, based on 
mass spectrometric data. Remarkably, they found that K
+
 preferentially binds benzene 
over a water molecule, suggesting that interactions of alkali metal cations with benzene 
could possibly be favorable in aqueous solutions. These mass spectrometric results were 
accompanied by ab initio computations, which established that cation is located along 
the C6 axis in these complexes, directly above the face of benzene (see Figure II-1).
81
  
Subsequent mass spectrometric studies by Guo et al.
82
 on non-bonded complexes of 
additional metal cations with benzene were in general agreement with the data from 
Kebarle and co-workers.
81
 In particular, Guo et al.
82
 reported stronger binding enthalpies 
for Na
+ 
with benzene (−28.0 kcal mol–1), compared to Na+ with H2O (−24.0 kcal mol
–1
).  
Cation–π interactions came to the forefront following pioneering work by 
Dougherty and co-workers
73,74
 in the early 1990s. This was spurred in part by the 
demonstration that cation–π interactions play key roles in biological systems.83-86  
Moreover, it was Dougherty and co-workers who originally coined the term “cation–π 
interaction” to describe interactions of positive ions with either aromatic rings or non-
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aromatic alkenes (e.g. ethene).
79,80
 Initially, in the early 1980s, Dougherty et al. 
focused
87-89
 on interactions of cations with aromatic host−guest systems through gas-
phase measurements and studies of receptors in aqueous media. Accompanying 
computational studies of prototypical cation–π complexes were later reported, 
emphasizing structures of relevance to biological receptors and heterocycles of 
importance in medicinal chemistry.  
In the 1990s, Lisy and co-workers
90
 studied the interaction of K
+ 
with benzene 
and water through vibrational spectroscopy.
 
In particular, they explored the competition 
between the interaction of K
+
 with benzene and water, leading to important observations 
on the preferential binding of K
+
 to benzene and the dehydration of K
+
 by benzene. Lisy 
et al.
91
 also showed that K
+
 displays higher selectivity towards aromatic systems in 
aqueous environments, as compared to Na
+
. This later led to a proposal of a size-specific 
mechanism for the interaction of alkali metal ions with aromatic side chains in some K
+
 
channel proteins. 
In 1996, Dougherty et al.
88,89
 showed that trends in cation–π interaction energies 
could be rationalized based on computed electrostatic potentials of aromatic rings. This 
provided a means of quantitatively predicting cation–π interactions based on 
straightforward computations applied to just the aromatic system, while also showing 
that molecular electrostatic potential (MEP) plots, such as those shown in Figure II-2, 
provide a powerful tool for qualitative predictions of both the geometry and strength of 
cation–π interactions. That is, cations will preferentially bind to areas of highly negative 
electrostatic potential, with the strength of binding proportional to the magnitude of the 
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negative electrostatic potential. Ultimately, the success in analyzing cation–π 
interactions in terms of electrostatic potentials solidified the now widespread view of 
cation–π interactions as primarily electrostatic in origin, as originally proposed by 
Kebarle.
81 
 
 
 
Figure II-2. Molecular electrostatic potential (MEP) plots of benzene, toluene, 
benzonitrile, and triazine. In these plots, the electrostatic potential is shown on an 
electron density isosurface (ρ = 0.001 e bohr–3). 
 
 
Although electrostatic effects have long been understood to underlie cation–π 
interactions, the significance of polarization (i.e. induction) effects in cation−π 
interactions has also been emphasized,
76,92-95
 most notably by Cubero et al.
92
 Such 
effects, in which the electron density of the arene is polarized by the presence of the 
cation, are mainly dependent on the size of the π system, while dependence on the nature 
of substitution is negligible. 
Physical Origin of Cation–π Interactions 
Superficially, the origin of attractive interactions between cations and the faces 
of aromatic rings is straightforward—the electron rich faces of arenes bind cations. For 
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example, MEP plots (see Figure II-2) reveal regions of negative electrostatic potential 
above the faces of aromatic rings such as benzene, indicating that cations will engage in 
attractive electrostatic interactions with the faces of such rings. More quantitatively, 
cation–π interactions are often discussed in terms of molecular quadrupole moments. In 
particular, the z
2
-component of the molecular quadrupole moment of benzene is –8.7 
B.
96,97
 This negative Qzz value arises from the abundance of negative charge along the z-
axis (i.e. the π-electron cloud) and positive charge away from the z-axis (i.e. the partially 
positive charged hydrogens). The result is a sizeable quadrupole moment suited to 
interact favorably with a positive charge located along the z-axis. Thus, as a first 
approximation, cation–π interactions can be viewed as electrostatic interactions between 
a charge and an electric quadrupole. 
However, as noted by Ma and Dougherty in their 1997 review,
73
 the cation–π 
interaction cannot be modeled quantitatively as a charge-quadrupole interaction. This is 
because the size of the arene is commensurate with the distance between the arene and 
cation (2–3 Å); any multipolar expansion of electrostatic interactions at such close 
proximities will be divergent. This weakness of the charge-quadrupole picture in 
describing cation–π interactions will be even more severe when considering larger 
arenes. 
Alternatively, one can view benzene as a collection of six radially-oriented 
dipoles, corresponding to the polarized C-H bonds. From this perspective, favorable 
cation–π interactions arise because a cation located above the center of the ring can 
interact with the positive end of each of these six local C-H dipoles. This local multipole 
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view of aromatic rings is more physically sound when discussing cation–π interactions 
with larger arenes, and also leads to a more satisfactory understanding of substituent 
effects in cation–π interactions.78,98-100 Such local multipole descriptions of the 
electrostatic component of non-covalent interactions have long been championed by 
Stone and co-workers,
101-104
 and are finding increasing use in modern molecular 
mechanics force fields.
105
 
Electrostatic potentials, which are widely used in discussions of non-covalent 
interactions, can provide a more rigorous means of predicting the electrostatic 
interaction between a cation and an aromatic ring.
88,89
 Formally, the electrostatic 
potential at a given point near a molecule is the electrostatic interaction that a positive 
test charge would experience at that point. Electrostatic potentials provide reliable 
predictions of relative interaction energies for cation–π complexes (vide infra), 
particularly in cases in which the arenes involved all have similar polarizabilities. 
However, despite their widespread use and utility in predicting cation–π interactions, 
MEP plots are widely misinterpreted,
98,106,107
 adding an additional layer of confusion to 
many discussions of cation–π interactions.  
Furthermore, as noted early on by Cubero and co-workers,
92
 as well as 
others,
76,93-95
 there are other, significant contributions to cation–π interactions beyond the 
simple electrostatic effects captured by electrostatic potentials and molecular quadrupole 
moments. Chief among these are due to induction effects, which refers to the enhanced 
interaction that arises from the relaxation of the electron density in each monomer in the 
presence of the other monomer (i.e. the mutual polarization of one monomer by the 
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other). Such effects are strongly dependent on the polarizability of the interacting 
species. Although molecular quadrupole moments provide a reasonably accurate 
description of relative cation–π interaction energies involving sets of similar arenes, this 
correlation can break down when the polarizability of the arenes differ significantly.
108
 
In these cases, variations in the contribution of induction lead to changes in the 
interaction energy that are not captured by the Qzz values.  
Sherrill and co-workers
76
 have performed density functional theory (DFT) based 
symmetry-adapted perturbation theory (SAPT) computations on model cation–π 
complexes. SAPT computations
109,110
 provide a rigorous dissection of non-covalent 
interaction energies into contributions from electrostatics, induction, dispersion, and 
exchange-repulsion (Pauli repulsion). Sherrill et al.
76
 confirmed previous reports
93-95
 that 
the contribution of dispersion interactions in cation–π interactions are small, contributing 
only 4% to the total binding of Na
+
 by benzene, for example. They also showed that, for 
this prototypical cation–π complex, induction effects are responsible for nearly half of 
the total binding energy, with the remainder being electrostatic in origin.  
Of course, induction alone is typically not sufficient for strong cation–π 
interactions, although it can lead to overall favorable binding, and a strong electrostatic 
component can be considered to be a defining characteristic of cation–π interactions.74  
For example, despite the greater polarizability of cyclohexane, compared to benzene, the 
former does not bind alkali metal cations nearly as well as the latter.
111
 Intriguingly, 
Sherrill and co-workers
76
 also revealed that alkali metal cations can also interact 
favorably with benzene in a “side-on” configuration. In this geometry, the mildly 
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repulsive electrostatic component of the interaction is overcome by strongly attractive 
induction terms, with a small contribution from dispersion effects. However, in our 
view, such complexes should not be referred to as cation–π complexes, because they are 
fundamentally different in origin. 
Finally, we turn briefly to the role of aromaticity in cation–π interactions. 
Although the original definition
79,80
 of cation–π interactions included interactions of 
cations with both aromatic and non-aromatic π-systems, there has been greater focus in 
recent years on cation–π interactions involving aromatic systems. This presumably arises 
in part from the prevalence of cation–π interactions in biological systems, in which 
cations interact with aromatic amino acid side chains. Somewhat unexpectedly, in 2011, 
Bloom and Wheeler recently showed
112
 that aromaticity actually enhances the strength 
of cation–π interactions. That is, an aromatic ring will bind a cation more strongly over 
its center than an otherwise identical non-aromatic cyclic conjugated polyene. This can 
be explained by the net influx of π-electron density toward the center of a cyclic polyene 
upon aromatic delocalization, and suggests that cation–π interactions are indeed 
“special”, unlike π–stacking and other non-covalent interactions involving aromatic 
rings.
112
 
Tuning the Strength of Cation–π Interactions 
One of the key features of cation–π interactions is the possibility of tuning their 
strength over a broad range. First, the strength of cation–π interactions depends strongly 
on the identity of the cation, with Li
+
 interacting with benzene far more strongly than 
either Na
+
 or K
+
 (see Figure II-1). However, for a given alkali metal cation, the strength 
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of cation–π interactions can also be widely tuned through substituent and heteroatom 
effects.
98
 Although this has long been established, our understanding of the origin of 
substituent and heteroatom effects in the strength of cation–π interactions continues to 
evolve.
78,99,100
  
 
 
 
Figure II-3. DFT computed interaction energies, relative to the unsubstituted case (X = 
H), for model complexes of Na
+
 above the center of monosubstituted benzenes, C6H5X, 
vs (a) the electrostatic potential computed at the position of the Na
+
 above the ring and 
(b) the Hammett σm constant for the substituent. Data from Ref. 
98
. 
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Cation–π interactions show marked sensitivity to substituents. For example, the 
interaction of Na
+
 with benzene in the gas-phase (–23.5 kcal mol–1)98 can be tuned over a 
range of at least 20 kcal mol
–1
 by adding a single substituent to the benzene. This can be 
seen in Figure II-3, in which relative gas-phase interaction energies of Na
+
 over the 
center of 25 monosubstituted benzenes are plotted. These interaction energies are 
strongly correlated with the computed electrostatic potential computed at the position of 
the anion above the ring (see Figure II-3a). They are also reasonably well-correlated 
with Hammett σm constants (see Figure II-3b), which can provide a qualitative guide to 
the strength of these interactions in substituted aromatic systems. Moreover, as with 
other non-covalent interactions involving aromatic rings,
78,99,100,113
 substituent effects in 
cation–π interactions are additive, providing access to an even greater range of 
interaction energies through the introduction of multiple substituents. 
Traditionally, substituent effects in cation–π interactions were rationalized based 
on the π-electron density of the substituted ring (see Figure II-4a). That is, electron 
donating groups (CH3, NH2, etc.) enhance cation–π interactions by increasing the π-
electron density of the ring. Similarly, electron-withdrawing groups (NO2, CN, etc) lead 
to weaker cation–π interactions through the depletion of the π-electron density of the 
aromatic ring. These notions are seemingly supported by MEP plots (see Figure II-2), 
and are reminiscent of the seminal model of aromatic interactions from Hunter and 
Sanders.
114
  For example, toluene binds Na
+
 more strongly than does benzonitrile, in 
accordance with qualitative predictions from the corresponding MEP plots, as well as 
conventional notions of the π-electron densities of these two aromatic systems.  
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Figure II-4. Competing models of substituent effects in cation–π interactions. (a) In 
conventional views, substituent effects arise from the modulation of the aromatic π-
electron density by the substituents. (b) In the local dipole model of Wheeler and 
Houk,
98
 substituent effects in cation–π interactions are dominated by the through-space 
electrostatic interaction of the local dipole associated with the substituent and the cation. 
Both models tend to provide similar predictions with regard to substituent effect trends. 
 
 
However, the origin of differences in electrostatic potentials of substituted 
arenes, as well as the interactions of these systems with cations, are widely 
misunderstood.
98,106
 In particular, substituent effects in cation–π interactions are not 
necessarily due to substituent-induced changes in the π-electron density. In 2009, 
Wheeler and Houk
98
 showed that both cation–π interactions and the electrostatic 
potentials above the centers of substituted benzenes can be accounted for by the through-
space effects of the substituents. There is no need to consider changes in the π-electron 
density caused by the substituents. This mirrors similar revelations regarding substituent 
effects in other non-covalent interactions involving aromatic rings, including π–stacking 
and anion–π interactions.99,100,115-120   
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Wheeler and Houk
106
 later extended these findings to MEP plots, which were 
similarly shown to have little to do with the distribution of π-electrons. In other words, 
the dramatic differences in the MEP plots of aniline, benzene, and benzonitrile (see 
Figure II-2) do not arise from underlying differences in π-electron density. Instead, 
Wheeler and Houk
106
 showed that substituent effects in the electrostatic potentials of 
arenes are dominated by through-space effects of the substituents. This can be 
understood in terms of the effect of the local dipole moment associated with the 
substituent on the electrostatic potential. This can be seen in Figure II-5, in which the 
electrostatic potential in the plane bisecting benzonitrile (leftmost image) is qualitatively 
reproduced by simply adding the electrostatic potential of HCN to that of benzene. In 
other words, the change in the electrostatic potential above benzene from negative to 
positive by adding a single CN substituent simply reflects the positive end of the local 
CN dipole, not any substantive changes in the π-electron density of the ring. 
 
 
 
Figure II-5. The electrostatic potential in the plane bisecting benzonitrile (left), as well 
as an additive approximation of this electrostatic potential constructed by adding the 
electrostatic potential in the plane bisecting benzene to the electrostatic potential of 
HCN. Reprinted with permission from Wheeler.
391
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Thus, the dominant factor in substituent effects in cation–π interactions is the 
interaction of the local dipole moment associated with the substituent and the cation (see 
Figure II-4b). This can be seen explicitly in Figure II-6, in which an accurate interaction 
potential for Na
+
 above the center of benzonitrile is reproduced quantitatively by adding 
a simple charge-dipole interaction to the interaction of Na
+
 with benzene. That is, no 
changes in the interaction of the cation with the aromatic ring itself are needed; instead, 
one only needs to account for the interaction of the cation with the local dipole 
associated with the nitrile substituent. This strongly supports the local dipole picture of 
substituent effects in π–stacking interactions,98 and precludes any substantial role of π-
electron density changes caused by the substituents. 
 
 
 
Figure II-6. Accurate gas-phase interaction energy of Na
+
 with benzene (gray line) and 
benzonitrile (black line) as a function of distance above the ring. Also shown are a 
simple charge-dipole interaction (red line) and the result of adding this charge-dipole 
term to the Na
+…
benzene interaction potential (red dashed line). Modified with 
permission from Wheeler.
391
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Recent work from Wheeler and Bloom
107
 suggests that there are similar 
misconceptions regarding the impact of heteroatoms on the ability of N-heterocycles to 
bind cations, which is often discussed in terms of π-electron densities. For example, 
Wheeler and Bloom showed that the increasingly positive electrostatic potentials of the 
symmetric azines pyridine, 1,4-pyrazine, 1,2,3-triazine, 1,2,4,5-tetrazine, and the 
hypothetical molecule hexazine have little to do with changes in the π-electron density. 
Indeed, the effect of introducing nitrogens into an aromatic ring is a net influx of π-
electron density towards the ring center!  For example, despite the strongly positive 
electrostatic potential above 1,3,5-triazine (see Figure II-2), there is actually more π-
electron density near the center of triazine than benzene. Although the impact of these 
effects on cation–π interactions has not been considered explicitly, related work on 
anion–π interactions107 suggests that the effect of N-heteroatoms on strength of cation–π 
interactions are not due to changes in the π-electron density. 
Regardless of the origin of the effects, both heteroatoms and substituents provide 
a simple and predictable means of tuning the strength of cation–π interactions. This 
tuning can be exploited in a myriad of chemical contexts, and contributes to the power of 
cation–π interactions. 
 
Spectroscopic Characterizations of Cation−π Interactions 
Over the past decade, mounting spectroscopic data on cation−π interactions121-123 
has provided many key insights into their nature and abundance. Nuclear magnetic 
resonance (NMR), mass spectrometry (MS), infrared spectroscopy (IR) and other 
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techniques have been widely applied in the characterization of these interactions. In 
particular, NMR has been used to detect and characterize cation−π interactions in 
aqueous solution and in the solid state. For example, Wu and co-workers
124,125
 
established NMR signatures for complexes containing cation−π interactions through 
solid-state NMR studies of tetraphenylborate salts. Alkali metal ions exhibit highly 
negative chemical shifts when bound to tetraphenylborate compounds, and this highly-
shielded environment at the metal center can be used to detect cation−π interactions. 
Gokel et al.
126
 used solid-state NMR to study cation−π interactions between Na+ and two 
lariat ether molecules, in which the sodium cation interacts with an indolyl group, while 
Cuc and co-workers
127
 investigated an inclusion complex of calix[4]arenes and Cs
+
 via 
diffusion NMR spectroscopy.  
Mass spectrometry has also been widely used as a tool to investigate the 
properties of cation−π complexes, as well as the intrinsic binding mode of different 
cations. For instance, Dunbar and co-workers
128-131
 utilized Fourier-transform ion 
cyclotron resonance (FT-ICR) ion trapping mass spectrometry to explore the binding 
mode of cations upon the formation of metal ion−π complexes with coronene,128 
complexes of Na
+
 with Ala and Phe amino acid side chains,
130
 and encapsulation of 
metal cations by Phe−Phe ligands.131 Armentrout et al.132 determined the binding 
energies of mono and bis-benzene complexes with alkali metal cations using Collision-
induced dissociation (CID). The observed trend in binding energies depended on the 
magnitudes of electrostatic interactions and ligand−ligand repulsions. Rodgers and co-
workers
133-141
 performed number of experiments on metal ion−π complexes using 
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threshold CID along with complementary computational studies. They showed that the 
strength of cation−π interactions of alkali metal ions with a variety of π-systems, 
including azines and other N-heterocycles, halobenzenes, toluene, and the aromatic 
amino acids Phe, Tyr, and Trp, depend both on nature of the π-group and any 
substituents present. Finally, mass spectrometry has been use to show that cation−π 
interactions enhance the formation of sandwich benzo-crown ether-alkali metal cation 
complexes with Na
+
, K
+
, and Cs
+
 ions.
142
  
Cation−π interactions of alkali metal−crown ether complexes were studied in the 
gas phase by Lisy et al.
143
 using infrared predissociation (IRPD) spectroscopy, 
accompanied by DFT computations and SAPT analyses. Recently, Dunbar et al.
131,144,145
 
investigated the encapsulation of metal cations by aromatic peptides using Infrared 
multiple photon dissociation (IRMPD) spectroscopy. The interplay between alkali ions 
and different di-, tripeptides, and Phe ligands were characterized. Alkali metal-ion 
complexes were shown to prefer charge-solvated binding modes since the zwitterion 
(salt bridge) complexes are less stable. Binding thermochemistry of cation−π complexes 
were also studied by Morel and co-worker.
146
  
A number of other spectroscopic techniques have been brought to bear on 
cation–π interactions. Schlamadinger et al.147 used UV resonance Raman (UVRR) 
spectroscopy to study the changes in vibrational structure upon formation of a cation−π 
complex. They observed systematic shifts in relative intensity in the 760−780 cm−1 
region when Na
+
 or K
+
 and the indole moieties of a crown ether coordinate through 
cation−π interactions. Ultraviolet second-derivative absorbance spectroscopy was 
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utilized by Lucas and co-workers
148
 to understand cation−π interactions involving 
aromatic residues in protein structures. In particular, structural information on eight 
different proteins was obtained by probing cation−π interactions and evaluating the 
empirical UV spectral data. 
Solid state structures have also been explored recently in order to shed additional 
light on cation−π interactions.149,150 For example, Gokel and co-workers22,48-58 employed 
their lariat ether model systems as a tool to detect cation−π interactions in the solid state 
for synthetic receptors bearing the aromatic amino acid side chains of Phe, Tyr, and 
Trp.
126,151-159 
Cation complexation has been attributed in part to the presence of flexible 
side arms that can compete with the counteranion. A diaza-18-crown-6 scaffold in the 
synthetic receptor model systems was determined to be the primary cation binding site in 
these systems, and modifications of its side arms modulate its ability to bind cations. 
Gokel et al.
160
 also studied cation transport through synthetic hydraphile channels 
comprising side arms with varying degrees of π-electron density. Cation−π interactions 
were demonstrated to play a vital role in obtaining a stable, active ion channel 
conformation. 
Finally, interaction energies between alkali metal ions and model π-systems in 
different phases were compared by Fukin et al.
161
 Cation–π interaction energies were 
found to follow the order Cs
+
 ≈ Rb+ > K+ > Na+ in the solid-state for 1:1 complexes of 
metal cations with hexakis-(methoxymethyl) benzene. This trend is notably different 
from the order observed in the gas-phase. In these systems, the capture of alkali-metal 
cations is facilitated by a pair of ether “tentacles”, which loosely position the cation over 
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the phenyl ring. X-ray crystallographic analyses
162
 of N-[3,5-bis(α,α-dimethylbenzyl-2-
hydroxybenzyl)] iminodiacetic acid, in which a potassium ion interacts with aromatic 
groups, reveal strong cation−π interactions of the metal ion with α,α-dimethylbenzyl 
groups. Finally, intramolecular interactions of tris(2,6-diisopropylphenoxy)-silanethiol 
and its Na
+
 salts were investigated by Dolega and co-workers.
163
 The sodium ion was 
shown to coordinate with the neutral phenyl rings by analyses of the crystal structure and 
through FT-IR spectroscopy. 
 
Cation−π Interactions in Host-Guest and Biological Systems 
Host guest complexes have been employed as powerful tools for characterizing 
molecular recognition between synthetic receptors and small guest molecules facilitated 
by cation−π interactions, shedding light on cation–π interactions with aromatic amino 
acid side chains. For example, in 1995, selective recognition of alkali metal cations by 
cyclophanes was reported by Inokuchi et al.
164
 Cage-like molecules featuring phenyl 
walls and caps were synthesized by Kim and co-workers
165
 in order to examine cation 
complexation, in which the selectivity for Li
+
 and NH4
+
 was governed by the gate size of 
the cage. Lelias-Vanderperre et al.
166
 studied cation recognition by macrotricycles 
comprising aromatic rings, reporting preferential binding of NH4
+
 over K
+
. Rathore and 
co-workers
167,168
 designed and synthesized a hexaaryl benzene (HAB) based receptor 
featuring a bipolar receptor site, which enhanced the binding ability of K
+
 by the 
synergistic effect of a polar ethereal fence and the central benzene ring through a 
cation−π interaction. Cametti and co-workers169 studied cation−π interactions between 
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alkali metal halide and uranyl-salophen receptors. Solid-state structures of complexes 
formed by the two armed uranyl−salophen complex receptors with CsF and with 
chlorides from KCl, RbCl, and CsCl reveal the existence of dimeric supramolecular 
assemblies in which two receptor units assemble into capsules fully enclosing (MX)2 ion 
quartets. Nissinen et al.
170,171
 used NMR and X-ray structure analyses to investigate 
cation−π interactions between the alkali metals K+, Rb+, and Cs+ and pyrogallerene and 
resorcinarene receptors. Strong cation−π interactions were identified, and both 
electrostatic complementarity and preorganization were shown to be critical of forming 
molecular cages. 
Host-guest complexes in which the cation is not located above the center of an 
aromatic ring have also explored computationally by Macias et al.
172
 Their 
computational results indicate that multiple weak, non-optimal cation–π interactions can 
contribute significantly to the overall binding strength. This analysis underscores the 
importance of neighboring aromatic faces and provides new insight into the significance 
of cation–π binding, not only for calix[4]arenes, but also for other supramolecular and 
biological systems.  
Cation−π interactions can play important roles in enzyme conformation and 
activity. For example, Wouters et al.
173
 showed that a cation−π interaction between Na+ 
and a nearby tryptophan in the crystal structure of tetragonal lysozyme adopts a 
conformation similar to that in model cation–π systems, while Pan and co-workers174 
found that a Phe residue is highly conserved in integrin α4β7, and engages in cation–π 
interactions that are crucial to the regulation of integrin affinity and signaling. Dougherty 
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et al.
175
 explored the interaction of Na
+
 and Ca
2+
 with aromatic residues in the external 
vestibule of the ion-conducting pores of a sodium channel. A cation–π interaction 
involving Ca
2+
 was confirmed by the linear response of Ca
2+
 blocking induced by 
increasingly fluorinating the aromatic ring. 
Williams and co-workers
176,177
 investigated the potential role for both divalent 
and monovalent cations in disrupting DNA and RNA structures and stabilizing the 
unstacked conformations through cation−π interactions. Cation−π interactions, as well as 
hydrogen bonds and π–stacking interactions between loop residues and the outer G-
quartets, have been suggested to all contribute to the formation and stability of DNA G-
quadruplexes.
178-181
 Analysis of a data set of mesophilic and thermophilic protein single 
chain models showed that cation−π interactions stabilize protein secondary structures, 
leading to higher rigidity and enhanced thermal stability. Finally, Matsumura et al.
182,183
 
demonstrated the presence of a unique cation–π interaction between Na+ and a Phe 
residue in the wild type T1 lipase of Geobacillus zalihae (see Figure II-7), the impact of 
which was quantified through molecular dynamics simulations.  
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Figure II-7. Structure of the T1 lipase studied by Matsumura et al.,
182
 which exhibits a 
well-defined cation–π interaction between Na+ and a nearby Phe residue (PDB: 2DSN). 
 
 
Cation−π Interactions in Materials Science 
Cation–π interactions have also received some interest in the realm of materials. 
For example, Ramamurthy and co-workers
184
 showed that aromatic molecules tend to 
aggregate within cation exchanged Y zeolites. Computations indicated a strong 
stabilizing effect arising from cation−π interactions, which is consistent with the 
formation of ground-state π-stacked aggregates of naphthalene molecules within Y 
zeolites. Ramamurthy et al.
185
 also probed the impact of cations on photochemistry 
inside zeolites, showing that cation–π interactions control the photochemical and 
photophysical behaviors of supercages of zeolite guest molecules.  
Although the interaction between neutral alkali metals and graphene or carbon 
nanotubes has been widely studied, there are surprisingly limited computational studies 
of cation−π interactions in nanosystems.186-188 Tachikawa et al.189 reported 
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computational studies on the interaction between Li
+ 
and the surface of amorphous 
carbon based on semiempirical MO theory and dynamics simulations. The results 
showed that Li
+
 tends to bind at the edges of model amorphous carbon clusters through 
peripheral cation−π interactions. More recently, Tachikawa et al.190 investigated the 
interaction of Li
+
 with C60, identifying distinct stable binding sites in which Li
+ 
interacts 
with either a five-membered ring or six-membered ring.  
Umadevi et al.
191
 used DFT to study the interaction of small molecules and ions 
with graphene, considering a series of linear and branched polycyclic aromatic 
hydrocarbon (PAH) systems as models. In a more comprehensive follow-up study,
192
 the 
effect of chirality and curvature of carbon nanotubes (CNT) on their interaction with 
alkali and alkali earth metal ions was explored, revealing that monocationic ions 
preferentially bind zigzag CNTs, whereas the dications bind more strongly to armchair 
CNTs. Valencia et al.
193
 studied the adsorption of alkali metal cations on graphite, using 
DFT to understand the structural, energetic, and electronic properties of these cation−π 
complexes. They suggested that one valence electron is entirely transferred from the 
alkali metal to the graphite surface, leading to a strong interaction between the lithium 
ion and the π-electrons of the graphite.  
Mpourmpakis et al.
194
 used ab initio computations and molecular mechanics 
simulations to show that the interactions of Li
+
, Na
+
, and K
+
 with carbon nanotubes are 
independent of the nanotube curvature. Cation−π interactions between alkali metal 
cations and C24-fullerene were investigated by Moradi and co-workers
195
 using DFT. 
They found that the ideal adsorption site is above the center of one six-membered ring 
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on the exterior surface of C24. Overall, the trend in binding of Li
+
, Na
+
, K
+
 follows that 
for smaller arenes, with larger cations binding more weakly. Related boron-doped 
fullerenes were shown to have stronger interaction energies, while a nitrogen-doped 
analogue bound cations more weakly. Finally, Hilder et al.
196
 used MD simulations to 
study the selectivity of cations permeating boron nitride nanotubes, showing that these 
nanotubes selectively allow monovalent cations to pass through while blocking 
anions.
197
  
 
Cation−π Interactions in Chemical Catalysis 
Recently, cation−π interactions involving alkali metal cations have also gained 
some attention from synthetic chemists, due to their potential utility in catalytic 
reactions. For example, Ramamurthy and co-workers
198
 reported the selective 
photoisomerization of diarylcyclopropanes arising from strong cation−π interactions that 
lead to preferential binding of alkali metal cations to ideally placed phenyl rings. 
Wooten et al.
199
 studied the impact cation−π interactions on the structure and binding of 
M3(sol)n(BINOLate)3Ln catalysts, while Monje and co-workers
200
 explored the 
stabilizing effect of cation–π interactions in organolithium chemistry via Sn-Li exchange 
equilibria. The interaction energy between Li
+ and the π-system of α-oxy-organolithium 
molecules was demonstrated to be comparable to that observed in systems containing Li-
N or Li-O interactions. Finally, a series of alkali metal cation functionalized 
titanosilicate molecular sieves were reported in which cyclohexene epoxidation with 
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H2O2 was demonstrated. Ultimately, a distinct relationship between catalytic activity and 
intermolecular cation–π interaction energies were reported.201 
 
Conclusions 
Cation–π interactions involving alkali metal cations have emerged as key non-
covalent interactions in modern chemistry, biology, and materials science. Although our 
understanding of the nature of these interactions continues to evolve, the confluence of 
spectroscopic and computational analyses has unveiled many key properties of these 
interactions, while also identifying cation–π interactions as important non-covalent 
interactions in a number of chemical contexts. Importantly, the strength of cation–π 
interactions can be systematically modulated through the introduction of substituents and 
heteroatoms into aromatic rings, providing a powerful means of tuning these interactions 
for uses in everything from materials to catalysis. 
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CHAPTER III 
AROMATIC INTERACTIONS MODULATE THE 5’-BASE SELECTIVITY OF THE 
DNA-BINDING AUTOANTIBODY ED-10
*
 
 
Introduction 
Systemic lupus erythematosus (SLE) is an autoimmune disease whose underlying 
cause is not fully understood.
202
 Anti-DNA antibodies (Abs) often play a crucial role in 
the disease pathogenesis by triggering kidney inflammation via antibody-DNA complex 
deposition.
203
 Several non-DNA ligands have been identified that bind to anti-DNA Abs, 
including both small molecules and macro biomolecules.
204,205
 Molecules that bind 
pathogenic anti-DNA Abs may prevent tissue damage and are considered potential 
therapeutic agents for the treatment of SLE.
206
 Thus, it is crucially important to elucidate 
the mechanisms by which anti-DNA Abs recognize diverse ligands in order to 
understand the roles that anti-DNA Abs play in autoimmune disease pathology, and for 
inhibitor design.
207
  
DNA-binding antibodies can also serve as models of DNA and RNA recognition 
by proteins,
208
 which underlie many key biological phenomena.
209-222
 These recognition 
phenomena depend on the interplay of sundry non-covalent interactions, and a complete 
elucidation of the general mechanism of base recognition by proteins has remained 
elusive. Selective recognition of DNA and RNA bases has long been attributed to 
                                                 
*
 Reprinted with permission from “Aromatic Interactions Modulate the 5’-Base Selectivity of the DNA-
binding Autoantibody ED-10” by Y. An and S. E. Wheeler, 2014. J. Phys. Chem. B 118, 5653. Copyright 
© 2014 American Chemical Society. 
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specific hydrogen bonding interactions.
223-227
 On the other hand, the role of aromatic 
amino acid residues [tyrosine (Tyr), tryptophan (Trp), phenylalanine (Phe), and histidine 
(His)] in these recognition processes has been a somewhat contentious issue, with 
previous attempts to quantify their role in DNA and RNA recognition based on statistical 
analyses of known protein-DNA structures leading to mixed conclusions.
228-232
 
However, because the strength of π-stacking interactions varies depending on the 
identity of the aromatic amino acid side chain and nucleobase,
233-237
 these interactions 
will necessarily impact base selectivity. What remains to be quantified, however, is the 
extent to which π-stacking interactions can impact base selectivity in specific DNA and 
RNA binding proteins. 
 
 
 
Figure III-1. 5’-dTdC-3’ binding site in ED-10. The dC binding pocket is the D-ARM 
of Tanner and co-workers.
238
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Anti-DNA antibodies are classified as either single-stranded (ss) or double-
stranded (ds) DNA-antibodies depending on what type of DNA they bind.
239-241
 So far, 
only a few crystal structures of ss-DNA-antibody complexes are available.
242-248
 Among 
these structures, ED-10, BV04-01, and DNA-1 are the best examples, with detailed 
information about affinity, structure, and sequence specificity.
242-248
 Based on available 
structural data, Tanner and co-workers identified a conserved and fundamental structural 
element responsible for the recognition of ssDNA, termed the “ssDNA-antibody 
recognition module” (D-ARM).238 The D-ARM consists of a tyrosine residue that stacks 
with the base and a glycine that forms a hydrogen bond with the base. 
Sanguineti et al.
249
 investigated the binding of a number of oligonucleotides to 
monoclonal Ab ED-10, which exhibits sub-nanomolar binding affinities. Some of their 
reported relative binding free energies are shown in Table III-1. They showed via 
fluorescence binding experiments and thermodynamic measurements that the 5’ end of 
ssDNA has the highest binding affinity,
249
 and that only the first two bases from the 5’ 
end (dTdC in the case of the native antigen) interact strongly with the antibody. 
Moreover, it was found that the binding affinity is insensitive to the oligonucleotide 
length, as long as the sequence 5’-dTdC is present. On the other hand, if the 5’-base is 
anything other than thymine, the binding free energy is about five kcal mol
−1
 less 
favorable. 
Sanguineti et al.
249
 also reported a 1.89 Å resolution crystal structure with a 
truncated 6-mer nucleotide bound. We note that in this crystal structure, the 6-mer has 
been cleaved, leaving 5’-dTdC-3’ bound, with the C3’ hydroxyl group missing from the 
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cytosine nucleotide. The binding site of ED-10 from this crystal structure is depicted in 
Figure III-1. Cytosine is located in the D-ARM, while thymine is bound in a similarly 
structured binding pocket. π-stacking interactions from the light chain complementarity-
determining region (LCDR) 1 and heavy chain complementarity-determining region 
(HCDR) 3 as well as hydrogen bonding interactions from LCDR3 are observed in the D-
ARM. The cytosine ring engages in π-stacking interactions with TyrL32 and is roughly 
perpendicular to the TrpH95 ring system in the tip of HCDR3. Cytosine also forms a 
hydrogen bond with the main-chain carbonyl from GlyL91. Missing from this binding 
pocket is the hydrogen bonding interaction with the L91 side chain, as seen in other 
examples of the D-ARM.
242-248
 Finally, cytosine also accepts a hydrogen bond from the 
main-chain amide of GlyH98. Sanguineti et al.
249
 showed that TyrH97 played an integral 
role in the binding of this dinucleotide, rearranging with large conformational changes to 
allow sub-nanomolar binding affinity.  
 
 
Table III-1. Experimental/MMGBSA predicted binding free energies/enthalpies (kcal 
mol
–1), relative to the native antigen, 5’-dTdC, for four 18mer 
oligonucleotides/dinucleotides bound to the native antibody (ED-10) and three point 
mutants. 
 ED-10  Point Mutants
b
 
 Exp
a
 MMGBSA   AlaH50 PheH50 TyrH50 
5’-dTdC 0.0        0.0                     0.0 0.0 0.0 
5’-dAdC 5.2        8.7                       2.8 6.5 5.4 
5’-dGdC 5.1        0.7                       - - - 
5’-dCdC 4.9        14.7                     - - - 
a
 Experimental binding free energies are for 18-mer oligonucleotides 
starting with the listed sequence. 
b  
For point mutants, enthalpies are calculated instead of free 
energies.
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The binding site for thymine is more extensive, featuring π-stacking interactions 
with TrpH50 and TrpH95, an edge-to-face interaction with TyrH33, and a hydrogen 
bond donated from AsnH35 (see Figure III-1). The presence of three flanking aromatic 
amino acid residues in the dT binding pocket appears to be unique among ss-DNA 
binding antibodies for which detailed structural information is available.
242-248
 As shown 
below, edge-to-face XH/π interactions with TyrH33 are vital for the 5’-dT selectivity 
exhibited by this antibody.
249
 
To date, there have been no detailed computational studies of the origin of base 
selectivity in anti-ssDNA binding antibodies. Herein, we present computational analyses 
of the binding of four dinucleotides to ED-10, as well as selected point-mutants. We 
utilize classical molecular mechanics based dynamics simulations
50
 and density 
functional theory (DFT) computations applied to a cluster model of the 5’-nucleotide 
binding sites.
250-254
 The primary aim is to identify the non-covalent interactions that give 
rise to the pronounced selectivity for 5’-dT exhibited by ED-10, and hence shed light on 
the origin of sequence selectivity and mode of antigen recognition in this anti-ssDNA 
antibody. 
 
Theoretical Methods 
We have explored the ssDNA antibody complex (ED-10) with the native antigen 
5’-dTdC bound as well as complexes with 5’-dAdC, 5’-dCdC, and 5’-dGdC. The crystal 
structure of ED-10 was extracted from PDB file 2OK0, in which the 5’-thymidine 
presents in an anti conformation. The 5’ nucleobase was mutated from thymine to 
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adenine, cytosine, and guanine using Pymol,
255
 with each mutated 5’ nucleoside kept as 
an anti conformer. The starting coordinates of each complex were generated by the 
AMBER package with hydrogens added.
256-258
 Each complex was solvated in a 100.0 Å 
× 74.2 Å × 82.3Å rectangular box of TIP3P water molecules.
259
 Na
+
 ions were added to 
neutralize the system. 
With the atoms of the ssDNA antibody complex fixed, the energy of each system 
was first minimized for 10,000 steps using steepest descent and conjugate gradient 
algorithms, followed by another 10,000 energy minimization steps without constraints. 
After energy minimization, each system was heated from 0K to 300K under constant 
pressure for a total of 300ps. A three staged density equilibration was applied, involving 
two initial steps with weak restraining forces and a third step without restraints for a total 
of 2ns. A 10ns simulation was then carried out for each protein-DNA complex using the 
Amber03 force field in an isothermal-isobaric (constant NPT) ensemble after the above 
2ns  equilibration.
46
 The coordinates of each complex were saved every 2ps and the 
temperature maintained at 300K via Langevin dynamics.
260
 The constant pressure of 1 
atm was kept using a Nose-Hoover barostat.
261
 The SHAKE algorithm was used to 
constrain bonds to hydrogen.
262
 The particle mesh Ewald method was employed to treat 
the long-range electrostatic interactions.
263
 
Binding enthalpies were estimated using MMGBSA (molecular 
mechanics/generalized Born model and surface area model) for each ssDNA antibody 
complex based on 1,000 frames recorded during the above-described 10 ns trajectories.
42
 
The single trajectory approach was used to calculate the binding enthalpy of dTdC, 
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dAdC, dGdC, and dCdC in ED-10. Due to the computational cost of normal mode 
analyses, the entropic contribution to the relative binding free energy was estimated 
based on normal mode analyses applied to 40 frames. The multiple trajectory approach 
to MMGBSA was also employed, and confirmed the trend of binding energy obtained 
using the single-trajectory approach.
59,264
 Finally, MMGBSA was also used to compute 
pairwise interactions between the 5’-base and key binding site residues by only 
considering interactions between pairs of atoms contained within these interacting 
species. 
These MD simulations were complemented by density functional theory (DFT) 
computations on cluster models of the 5’ binding site at the B97-D/TZV(2d,2p) level of 
theory.
265-267
 This was done primarily to quantify the non-covalent interactions between 
ssDNA and the binding site amino acid residues. The B97-D functional provides 
accurate predictions of dispersion-dominated non-covalent interactions, including the π-
stacking, CH/π and NH/π interactions that are germane to this study.68,268-270 Binding site 
amino acids were defined as all the residues within 5Å of the 5’ nucleobase. The sugar 
ring and phosphate of the nucleotides were removed and open valences were capped 
with hydrogen atoms. To model an amino acid or groups of linked amino acids in the 
binding site, the terminal peptide bonds were cut. The open valence on NH was capped 
with hydrogen and a methyl group was added to the carbonyl. The positions of all of the 
hydrogen atoms were optimized with the remainder of the atoms fixed in space. For the 
native antigen, dTdC, we performed DFT computations on both the crystal structure 
binding site geometry as well as the average structure from the MD simulations. The 
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DFT computations for the other dinucleotides were based on the average MD structure, 
followed by 10,000 steps of energy minimization. Both the interaction energy of the 
overall binding pocket and the interaction energies between the 5’ based and key 
residues were evaluated. The interaction energy was computed as the difference in 
energy between the bound complex and the separated interacting species, all at the 
complex geometry. All DFT predicted interaction energies correspond to gas-phase 
computations, which should provide a reasonable model for the interactions within the 
hydrophobic core of the protein. However, we also evaluated solution-phase interaction 
energies for the 5’ bases with the entire 5’-binding site, to gauge the effect of solvation. 
The resulting interaction energies are in qualitative agreement with the gas-phase 
computations (see Table A-3). All DFT computations were performed using Gaussian09 
and utilized density fitting techniques.
271
  
 
Results and Discussion 
Binding of the Native Antigen (dTdC) 
First, we discuss the binding of the native antigen, dTdC, by ED-10. In the 
crystal structure geometry (Figure III-1), B97-D applied to a model of the binding site 
indicates that the strongest interactions involving thymine are the π-stacking interactions 
with TrpH95 and TrpH50, followed by the hydrogen-bonding interaction with AsnH35 
and the NH/π interaction with TyrH33 (see Table III-2). It is notable the hydrogen 
bonding interaction with AsnH35 provides less stabilization of this complex than the π-
stacking interactions with Trp residues. As seen below, hydrogen bonding also plays 
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only a minor role in the selectivity for the 5’-base. For cytosine, the strongest interaction 
stems from the loop containing TrpH95, ThrH96, TyrH97, GlyH98 and SerH99, which 
together contribute about –13.8 kcal mol–1 to the overall binding energy. This is 
complemented by strong hydrogen bonding interactions with GlyL91 and the π-stacking 
interaction between cytosine and TyrL32 (Table A-1 in Appendix). Overall, the DFT-
predicted interaction energy between dT and the 5’ binding pocket residues in ED-10 is 
–35.0 kcal mol–1. 
 
 
Table III-2. B97-D total and pairwise interaction energies (kcal mol
–1) between the 5’ 
base and key amino acid residues for four dinucleotides with ED-10.
a
 
            B97-D 
Res. dTdC dAdC dGdC dCdC 
TrpH50 –8.6 (–8.4) –6.0 –9.6 –5.6 
TrpH95 –7.7 (–8.9) –8.0 –9.9 –3.5 
AsnH35 –7.8 (–6.7) –9.2 – 0.4 
TyrH33 –8.9 (–6.3) –2.9 –17.8c –3.1 
GlyL91 –2.5 (–2.6) –3.6 –2.5 –3.2 
TyrH97 –0.3 (–2.6) –0.3 –3.8 –7.9 
Total
b
 –38.8 (–35.0) –32.7 –45.2 –22.8 
a 
For dTdC, B97-D interaction energies for the crystal structure geometry are 
provided in parentheses.
 
b
 Total B97-D interaction energy of the 5’ base with the binding site of ED-10. 
c
 Interaction of G with TyrH33-MetH34-AsnH35. 
   
 
The binding site of ED-10 from the averaged structures over the 10ns trajectory 
showed some qualitative deviations from the crystal structure. These differences could 
arise in part to the presence of the C3’ hydroxyl group on the cytosine nucleotide, which 
was absent in the reported crystal structure. During the dynamics simulation, the 
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conformation of the dinucleotide does not undergo significant changes, but is 
accompanied by movement of Phe96, Trp268, Ser276, and Ile101 towards dT. The result 
is a slight compression of the binding site. However, the primary intermolecular 
interactions depicted in Figure III-1 are maintained throughout the trajectory. B97-D 
interaction energies based on the average MD structure indicate some re-ordering of the 
important non-covalent interactions relative to those in the crystal structure geometry, 
and an overall slight enhancement of the predicted binding of thymine to –38.8 kcal mol–
1. In particular, based on the average structure, DFT predicts that the NH/π interaction 
between thymine and TyrH33 is now stronger than the stacking interactions with 
tryptophan.  
 
 
Table III-3. MMGBSA pairwise interaction enthalpies between the 5’ base and key 
amino acid residues, as well as total binding ethalpies (ΔH) and binding free energies 
(ΔG) for four dinucleotides with ED-10. All values in kcal mol–1. 
            MMGBSA 
Res. dTdC dAdC dGdC dCdC 
TrpH50 –4.8 –2.5 –5.5 –2.9 
TrpH95 –4.6 –4.7 –4.7 –1.9 
AsnH35 –3.5 –3.7 –3.8 0 
TyrH33 –3.2 –1.4 –4.3 –2.2 
GlyL91 –2.8 –1.8 –2.6 –1.1 
TyrH97 –1.1 –1.9 –1.2 –2.8 
ΔH –42.7 –33.4 –41.8 –25.7 
ΔG –20.3 –11.6 –19.6 –5.6 
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Origin of 5’-Base Selectivity 
The total MMGBSA predicted binding enthalpy for dTdC in ED-10 is –42.7 kcal 
mol
–1
. The main favorable non-covalent interactions involving thymine are π-stacking 
interactions with TrpH50 and TrpH95, hydrogen bonding interactions with AsnH35 and 
GlyL91, and an NH/π interaction with TyrH33 (see Table III-3), which is generally 
consistent with the DFT results for the binding site cluster model. For cytosine, the most 
favorable interaction is the hydrogen bonding interaction between NH on HisL27 and 
the phosphate group on cytosine. The interaction between the hydroxyl group on TyrH97 
and the deoxyribose-phosphate backbone of 3’ cytosine is also highly favorable. Other 
key interactions are the stacking interaction with TyrL32 and hydrogen bonding 
interactions with GlyH98 (Table A-1 in Appendix). Accounting for entropic effects, the 
predicted binding free energy for dTdC is –20.3 kcal mol–1. 
Experimentally, Sanguineti et al. showed that altering the 5’ nucleobase 
drastically reduces the binding affinity (see Table III-1).
249
 Below, we consider the 
binding of 5’-dTdC-3’ and three other dinucleotides (dAdC, dGdC, and dCdC) to ED-
10, in order to quantify the interactions that underlie the strong selectivity for 5’-dT. 
Table III-3 shows the total MMGBSA binding free energies and enthalpies for these four 
dinucleotides, as well as the pairwise interactions between the 5’ base and its 
surrounding residues. Predicted binding enthalpies relative to dTdC are listed in Table 
III-1. MMGBSA results also show that for all four dinucleotides, the interactions 
involving the 3’ base (cytosine) are relatively unchanged (Table A-1). That is, the base 
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selectivity at the 5’ end stems from changes in interactions with the 5’ base itself, not 
secondary effects impacting the 3’ binding pocket. 
The MMGBSA data indicate that dAdC, dGdC, and dGdC are all bound less 
strongly than the native antigen (dTdC), as observed experimentally.
249
  However, the 
magnitude of the change in binding observed experimentally (about 5 kcal mol
–1
, 
regardless of the base)
49
 is overestimated in the case of dCdC and underestimated for 
dGdC. In the former case, this is potentially due to rearrangements of TyrH97 and 
TrpH95 in the binding site upon binding of dCdC
249
 that were not captured by the MD 
simulations. Regardless, these results should still provide qualitative insight into the 
origin of 5’-dT selectivity in ED-10.  
 
 
Table III-4. Mean distances (in Å) for key non-covalent interactions.
a 
Res. Interaction dTdC dAdC dGdC dCdC 
TrpH50 π-stacking 3.6 (98%) 4.5 (0%) 3.6 (99%) 3.8 (79%) 
TrpH95 π-stacking 3.6 (98%) 3.6 (97%) 3.7 (94%) 5.4 (0%) 
TyrH33 XH/π 2.8 3.5 2.4 2.6 
AsnH35 H-bond  1.9 (79%) 2.2 (13%) 2.3 (53%) >4 (0%) 
a
 Values in parentheses are the percent of the MD snapshots in which 
the centroid-centroid distance was less than 4 Å for π-stacking 
interactions and the H
…
X distance was less than 2 Å for hydrogen 
bonds.  
 
 
For dAdC, MMGBSA predicts a binding enthalpy that is 9.3 kcal mol
–1 
less 
favorable than dTdC. This arises primarily from the reduced strength of the π-stacking 
and edge-to-face interactions with TrpH50 and TyrH33. The decreased strength of these 
interactions is reflected in the average distances between relevant groups (see Table III-
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4), which show a considerably larger separation between adenine and both TrpH50 and 
TyrH33 compared with dTdC. The hydrogen bond to GlyL91, which primarily involves 
the phosphate group, is also reduced slightly with dAdC bound compared to dTdC, 
which is again reflected in both the MMGBSA pairwise interaction energy and the 
average distance. Notably, the other major interactions in the binding pocket show little 
change. In particular, the hydrogen bonding interaction with AsnH35 is at least as strong 
in dAdC as in the native antigen, dTdC. Overall, MMGBSA predicts that 2.3 kcal mol
–1
 
of the preferential binding of dT over dA arises from differences in π-stacking 
interactions with TrpH50, while differences between the edge-to-face interactions of the 
nucleobase with TyrH33 account for 1.8 kcal mol
–1
 of the different in binding enthalpy. 
After inclusion of the entropic contribution, the predicted binding free energy for dAdC 
is 8.7 kcal mol
–1 
less favorable than for dTdC. 
These findings are further supported by B97-D interaction energies, which show 
that the interaction of adenine with the binding site is 6.1 kcal mol
–1
 less favorable than 
that of thymine. As seen in the MMGBSA results, this drop is due primarily to 
reductions in the strength of the π-stacking interactions with TrpH50 and the edge-to-
face interaction with TyrH33. In the latter case, the NH/π interaction between thymine 
and TyrH33 (–8.9 kcal mol–1) is replaced with a much weaker CH/π interaction between 
adenine and TyrH33 (–2.9 kcal mol–1), contributing significantly to the preferential 
binding of dTdC over dAdC. Similarly, B97-D predicts that the π-stacking interaction 
between adenine and TrpH50 is 2.6 kcal mol
–1
 less favorable than the corresponding 
interaction involving thymine. Thus, even though some of the other interactions 
 50 
 
operative in the binding site are stronger for adenine (most notably the H-bond to 
AsnH35), these enhanced interactions are overshadowed by the reduced π-stacking and 
XH/π interactions with aromatic amino acid side chains. 
For dCdC, both B97-D and MMGBSA predict a precipitous drop in binding 
strength compared to dTdC, due to a reduction in the strength of nearly all interactions 
with the binding site. Indeed, the strongest interaction with the 5’-dC is the π-stacking 
interaction with TrpH50, which is predicted to be 2 kcal mol
–1
 weaker than for dTdC. 
Given the lack of a suitable H-bond acceptor on cytosine, the H-bonding interaction with 
AsnH35 observed for dTdC and dAdC is not present with dCdC bound. Indeed, B97-D 
predicts that the interaction between AsnH35 and the 5’ cytosine is slightly repulsive. 
These significantly reduced interaction energies are offset slightly by the presence of 
TyrH97, which provides a favorable interaction with 5’-dC that is not present with any 
of the other bound dinucleotides. Overall, the present results indicate that selectivity for 
5’-dT over dC arises from a combination of hydrogen bonding, edge-to-face, and π-
stacking interactions. 
For dGdC, MMGBSA predicts only a 0.9 kcal mol
–1
 reduction in binding 
enthalpy, and a 0.7 kcal mol
–1
 reduction in binding free energy, relative to dTdC. 
Moreover, B97-D predicts a more favorable overall interaction between guanine and the 
binding pocket compared to thymine. In particular, the π-stacking interactions of guanine 
with TrpH50 and TrpH95 and the NH/π interaction with TyrH33 are both predicted to be 
more favorable compared to the analogous interactions with thymine, and the π-stacking 
interactions present in the case of guanine are predicted by B97-D to be the most 
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favorable of any of the dinucleotides. These favorable effects for dGdC are somewhat 
compensated for by other effects. However, overall neither MMGBSA nor B97-D 
reproduce the experimentally observed 5 kcal mol
–1
 drop in binding affinity for dGdC 
compared to dTdC. 
We have investigated two potential sources of this discrepancy. First, we note 
that in all the above complexes, the 5’ nucleosides (dT, dA, dC, and dG) adopt anti 
conformation throughout the simulations. We performed analogous simulations with the 
5’ nucleosides with a syn conformation, to test whether the non-native antigens, and 
dGdC in particular, binds in a different confirmation than dTdC. However, MMGBSA 
predicted binding enthalpies were less favorable for the syn conformer, compared to the 
anti conformer, for each of the dinucleotides considered. Thus, it does not appear that the 
5’-base of the non-native antigens adopt a different conformation than in dTdC. Second, 
we carried out multiple trajectory MMGBSA computations to investigate whether 
differences in confirmations of the bound and free dinucleotides were contributing to the 
experimental observation of reduced binding free energies for the other dinucleotides. 
As seen with the single trajectory results, these multiple trajectory simulations (see Table 
A-2) show that as 5’-dT is replaced with either dA or dC, the binding enthalpy drops by 
a significant amount. However, dGdC is predicted to bind slightly more strongly than the 
native antigen dTdC. That is, both multiple and single trajectory approaches predict 
similar binding trend for ssDNA. 
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Impact of TrpH50 Mutations 
The above results demonstrated that π-stacking interactions between the 5’ 
nucleobase and TrpH50 contribute strongly to the preferential binding of dTdC over 
dAdC. To probe the importance of this interaction further, we considered mutation of 
TrpH50 to Ala, Phe, or Tyr (see Table III-5). 
For all three point mutants, the binding enthalpy of dTdC becomes less 
favorable, while the binding of dAdC is predicted to be more favorable. In other words, 
although these point mutants are still predicted to be selective for 5’-dT, these mutations 
reduce the selectivity compared to the native antibody ED-10. The largest change in 
selectivity is predicted for the AlaH50 mutant, for which dTdC is predicted to be bound 
by only 2.8 kcal mol
–1
 more than dAdC, compared to the 9.3 kcal mol
–1
 difference for 
native ED-10. 
The origin of this reduced selectivity can be seen by again examining the 
individual interactions within the binding pockets. For all three point mutants, the 
interactions in the cytosine pocket are unperturbed relative to those in the native 
antibody. Moreover, most of the interactions present in the binding site change very 
little, and the overall changes in binding enthalpy are due primarily to differences in the 
interaction of the 5’-base with the H50 residue as well as secondary effects on the 
interaction with TyrH33. In particular, for the AlaH50 mutant, the reduced selectivity for 
dTdC over dAdC arises from changes in the interactions involving GlyL91 and TyrH33.  
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Table III-5. MMGBSA predicted total binding enthalpy and pairwise interactions (kcal 
mol
–1) between the 5’ base and key amino acid residues for TrpH50 mutants and the 
dTdC and dAdC dinucleotides. 
dTdC TrpH50 
(native) 
AlaH50 PheH50 TyrH50 
ResH50 –4.8 –0.9 –3.7 –3.8 
TrpH95 –4.6 –4.2 –4.5 –4.5 
AsnH35 –3.5 –3.5 –3.5 –3.5 
TyrH33 –3.2 –3.5 –3.5 –3.2 
GlyL91 –2.8 –2.9 –2.7 –2.8 
TyrH97 –1.1 –1.0 –1.4 –1.3 
Total –42.7 –40.4 –41.5 –41.3 
dAdC     
ResH50 –2.5 –0.6 –1.6 –1.3 
TrpH95 –4.7 –4.5 –4.8 –4.6 
AsnH35 –3.7 –3.9 –3.8 –3.1 
TyrH33 –1.4 –1.2 –1.4 –0.9 
GlyL91 –1.8 –2.3 –2.4 –2.9 
TyrH97 –1.9 –0.9 –1.6 –2.1 
Total –33.4 -37.6 –35 –35.9 
 
 
Summary and Concluding Remarks 
Binding free energies and enthalpies for four dinucleotides (dAdC, dGdC, dCdC, 
and the native antigen, dTdC) by ED-10 were computed using MMGBSA, and further 
analyzed using DFT applied to cluster models of the binding sites. Overall, MMGBSA 
provides relative binding enthalpies that are in qualitative agreement with experimental 
data for two of the three non–native dinucleotides (dAdC and dCdC), while for dGdC, 
MMGBSA appears to overestimate the binding affinity relative to dTdC. The MMGBSA 
data show that the affinity of ED-10 for the 3’ cytosine is relatively constant across the 
four dinucleotides, and the strong selectivity for dTdC arises primarily through 
differences in interactions within the 5’ binding site.  
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Analyses of the non–covalent interactions operative in the 5’ binding site reveal a 
number of key interactions. In particular, MMGBSA results show that for dTdC and 
dGdC, stacking interactions of the 5’ base with TrpH50 and TrpH95 contribute a total of 
about –10 kcal mol–1 to the binding enthalpy. However, the other two dinucleotides 
(dAdC and dCdC) show weaker overall binding, and π-stacking interactions of the 5’ 
base with TrpH50 are reduced significantly. Hence, π-stacking interactions with TrpH50 
not only contribute to dinucleotide binding, but are also central to the 5’-base selectivity 
of ED-10. Overall, the strong selectivity of ED-10 for dTdC over dAdC arises primarily 
from differential π-
interactions between the nucleobase and TyrH33. We note that this Tyr residue is not 
present in other ssDNA-binding autoantibodies, suggesting that these other antibodies 
will not exhibit the same strong 5’-base selectivity as ED-10. Similarly, MMGBSA 
computations predict that mutations of TrpH50 will provide measurable reductions in the 
selectivity for dTdC over dAdC, providing an experimental means of quantifying the 
role of π-stacking interactions in the 5’-base selectivity of this DNA-binding 
autoantibody. 
Overall, both MMGBSA and B97-D data show that π-stacking, CH/π, NH/π, and 
hydrogen bonding interactions all contribute to the binding of the 5’-base in complexes 
of dinucleotides with ED-10. However, these results demonstrate that the strong 
selectivity for 5’-dT sequences is primarily a result of differences in aromatic 
interactions (XH/ π  and π-stacking interactions), not hydrogen-bonding.   
 55 
 
CHAPTER IV  
QUANTIFYING THE Π-STACKING INTERACTIONS IN NITROARENE BINDING 
SITES OF PROTEINS
*
 
 
Introduction 
Nitroarenes, which are widely used components of explosives, dyes, pesticides and 
pharmaceutical feedstocks, are also common environmental pollutants and potent 
carcinogens.
272,273
 In nature, nitroarenes are metabolized primarily through bacterial 
degradation, for which they serve as a source of carbon, nitrogen, and energy.
273-276
 In 
humans, nitroarenes can interact with proteins and DNA, leading to mutagenicity and 
cytotoxicity.
277
 For instance, 1-10% of myeloma proteins bind nitrophenyl ligands.
278
  
Despite the prevalence of nitroarene binding sites in proteins, little is known about the 
nature of these binding sites, or how nitroarenes interact with aromatic amino acid side 
chains. 
Some nitroaromatic compounds are bioactive, and are present in a limited number 
of pharmaceuticals.
279
 For example, nitroarene-containing natural products exhibit 
antibiotic
272,280
 and antifungal
281,282
 activity. Similarly, synthetic nitroarenes have 
showed potential as therapeutic agents.
283
 For example, Miller and co-workers recently 
devised anti-tuberculosis agents based on nitroaromatic compounds,
284
 while Málnási-
Csizmadia et al. synthesized a non-cytotoxic and photostable analog of the well-known 
myosin II inhibitor blebbistatin by nitrating C15.
285
 Even though nitroaromatic 
                                                 
*
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compounds are not ordinarily produced biosynthetically, nitroarene binding sites abound 
in human cells. For instance, in the human bloodstream, 1% of all immunoglobulins 
react with nitroarene epitopes,
286,287
 and anti-dinitrophenyl (anti-DNP) antibodies have 
high prevalence in humans.
288,289
 Ligands exploiting these nitroarene binding sites have 
been designed to mediate immunogenicity,
290-292
 and dinitrophenyl containing ligands 
have been designed to target a number of diseases, including HIV,
293
 lung cancer,
294-297
 
prostate cancer,
298
 glioblastoma,
299
 and B cell lymphoma.
300,301
 
The Spiegel group has demonstrated the power of using nitroarene ligands as 
antibody recruiting molecules (ARM).
302-305
 In 2009, Spiegel et al. reported a new 
antibody-recruiting nitroarene ligand targeting HIV gp120.
306
 A ternary complex formed 
between anti-DNP antibodies, an ARM featuring a dinitrophenyl ring, and target cells 
was able to inactivate the virus. In the same year, Spiegel and co-workers designed a 
similar bifunctional small molecule drug targeting prostate cancer cells.
298
 This ligand 
binds prostate specific membrane antigen (PSMA) on the membrane of prostate cancer 
cells, recruiting an anti-DNP antibody via its nitroarene terminus. In 2010 a previously 
unreported remote nitroarene binding site on PSMA was discovered by Spiegel and co-
workers.
307
 This binding site features a nitroarene-tryptophan stacking interaction, which 
was postulated to enhance the ligand binding affinity with PSMA. More recently, Pires 
et al. developed a D-amino acid antibody recruitment therapy (DART) approach 
utilizing anti-DNP antibodies.
308
 This novel strategy involves the incorporation of non-
natural D-amino acids onto the cell surfaces of bacteria, which then redirect antibodies 
to the bacterial cell surface. This provides a potential means of eliminating Gram-
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positive bacteria by leveraging the power of the host immune system. Both of these 
novel biological applications could benefit from the more refined understanding of the 
binding of nitroarenes by proteins that can be provided by computational studies. 
The majority of previous computational studies of substituent effects in π-stacking 
interactions have focused on the benzene dimer, providing insights into the factors that 
impact the strength of these interactions. Notably, Sherrill and co-workers
113,309
 
demonstrated strict additivity of substituent effects in stacked benzene dimers. That is, 
the impact of several substituents on a given stacked dimer is simply the sum of effects 
of individual substituents. We have shown that these, and other trends in substituent 
effects in π-stacking interactions, are readily explained by the local, direct interaction 
model of substituent effects in π-stacking interactions.78,99,100,115,119,120 In contrast to 
venerable models of π-stacking interactions that center on the π-electron density of the 
interacting rings,
114,310-312
 substituent effects in diverse π-stacking interactions can be 
explained in terms of direct, local interactions between the substituents and the other 
ring.
78,99,100,115,119,120
 
These and other advances in our understanding of π-stacking interactions can be 
brought to bear on π-stacking interactions in biological contexts.313,314 Wetmore and co-
workers
233-236,254,315-324
 have used computations to study π-stacking interactions of 
aromatic amino acid side chains with increasingly sophisticated models of DNA, 
providing key insights into DNA-repair mechanisms and DNA intercalation phenomena, 
among others. Tschumper et al.
237,325
 recently presented computational studies of π-
stacking interactions of phenylalanine and tyrosine with adenine in protein structures. 
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However, there has been no analogous study of the interactions of nitroarenes with 
aromatic amino acid side chains.  
Many protein structures featuring bound nitroarene ligands have been deposited in 
the protein data bank (PDB), representing numerous families of enzymes 
(monooxygenases, dioxygenases, and reductases, among others). Two representative 
examples are depicted in Figure IV-1. In Figure IV-1a, a substituted m-dinitrophenyl 
ring is stacked with a Trp residue; in Figure IV-1b a similar nitroarene is stacked with a 
Trp and engages in a loose stacking interaction with a nearby Tyr residue. Despite the 
prevalence of nitroarene binding sites in proteins, and the demonstrated utility of these 
binding sites in the development of novel therapies,
294-308
 there have been no detailed 
analyses of the non-covalent interactions responsible for the binding of nitroarenes by 
proteins. As such, a thorough understanding of non-covalent interaction between 
nitroarenes and proteins is needed.  
 
 
 
Figure IV-1. Representative nitroarene binding sites in proteins: (a) the remote DNP 
binding site of ARM in PMSA from Spiegel and co-workers (PDB: 2XEF)
307
 and (b) a 
dinitrophenol binding site in the antibody SPE7 from Tawfik and co-workers (PDB: 
1OAU)
326
. In this case, the nitroarene is sandwiched between Trp and Tyr side chains. In 
both cases, the strength of π-stacking interactions are provided in kcal mol–1. 
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In 2009, Spiegel and co-workers
298
 published a limited analysis of nitroarene 
binding sites in the PDB, reporting that 16 of 32 available nitroarene-protein complexes 
exhibit π-stacking interactions between the nitroarene and aromatic amino acid side 
chains. Herein, we present a systematic study of model π-stacking interactions between 
nitrobenzenes and aromatic amino acid side chains in protein, accompanied by a much 
broader analysis of nitroarene binding sites present in proteins in the PDB. The results 
reveal that nitroarene binding sites are prevalent in protein structures, with interactions 
between aromatic amino acid side chains contributing as much as 14 kcal mol
–1
 to the 
binding of nitroarenes. Among the aromatic amino acids, Trp is particularly well-
represented in these binding sites, which is consistent with our finding that Trp side 
chains provide stronger stacking interactions with nitroarenes than His, Phe, or Tyr. 
 
Theoretical Methods 
Stacking interactions between nitrobenzene (1-NO2), m-dinitrobenzene (2-NO2m), 
p-dinitrobenzene (2-NO2p), and 1,3,5-trinitrobenzene (3-NO2) and aromatic amino acids 
side chains (histidine, phenylalanine, tryptophan and tyrosine) were computed at several 
different levels of theory. The amino acid side chains were modeled as shown in Scheme 
IV-1. In order to locate all stacked complexes involving these rings, initial geometries 
were generated by separating the amino acid and nitroarene by 4.0 Å, with the two 
systems parallel. We then explored all possible relative orientations at 30° increments at 
each of five different starting locations.
327
 Geometries were then fully optimized at the 
B97-D/TZV(2d,2p) level of theory. Binding energies were computed as the difference in 
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energy between the optimized dimer and the optimized monomers for all unique 
complexes, which were defined as the set of structures for which the root mean squared 
deviation (RMSD) with all other structures exceeds 0.5 Å. The binding energies for the 
global minimum structure for each nitroarene-amino acid pair were further quantified by 
higher-level ab initio methods. In particular, counterpoise-corrected CCSD(T)/aug-cc-
pVTZ interaction energies were esimated by 
 
CCSD(T)/AVTZ ≈ MP2/AVTZ + [CCSD(T)/jun-cc-pVDZ – MP2/jun-cc-pVDZ] 
 
where AVDZ denotes the augmented correlation-consistent basis set (aug-cc-pVDZ) of 
Dunning
328
 and jun-cc-pVDZ is the partially-augmented subset of the aug-cc-pVDZ 
basis devised by Papajak and Truhlar.
329
 Symmetry adapted purtubation theory 
computations
109,110,330,331
 (SAPT0) were also performed using the jun-cc-pVDZ basis set 
at these lowest-lying B97-D optimized structures. This level of SAPT-theory has been 
shown to provide excellent predictions across a broad range of non-covalent interactions 
at a very modest computational cost.
332
 
Stacking interactions between nitroarenes and aromatic amino acids were also 
culled from crystal structures in the PDB. We identified protein structures with ligands 
containing a benzene ring with at least one nitro group, X-ray resolution less than 2.5Å, 
and protein sequence identity less than 70%. Aromatic residues (His, Phe, Trp, and Tyr) 
were identified that were engaged in π-stacking interactions with each nitroarene ligand. 
The position of aromatic amino acid residues relative to the bound nitroarenes were 
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characterized based on the intermolecular coordinates shown in Figure IV-2, and π-
stacking interactions were defined as those for which R < 5Å, α < 45°, and β < 45°. All 
other structures were excluded from the subsequent analyses. 
 
 
Scheme IV-1 
 
 
 
The structures extracted from the PDB files were further refined based on the 
structures of protein and ligand. First, in nearly all of the identified structures, the 
nitroarene is part of a larger ligand. To isolate the interaction of the protein with just the 
nitroarene component, we removed the non-nitroarene part at the closest carbon to the 
nitrophneyl ring (usually the first or the second carbon depending on the structure of the 
ligand). Small substituents (1-2 heavy atoms) on the nitroarene rings were retained. 
Ligands in which the nitroarene was fused with another aromatic ring were not 
considered in our analyses. Second, in cases in which the protein was an oligmer and the 
same nitroarene-amino acid pair occurs multiple times, we considered only one instance 
of this interaction in our analyses. Finally, in proteins in which the nitroarene engaged in 
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stacking interactions with multiple aromatic amino acids, we considered each interaction 
separately. The final number of stacking interactions meeting these criteria was 65.  
To evaluate interaction energies for these 65 stacked complexes, hydrogens were 
added and their positions optimized at the B97-D/TZV(2d,2p) level of theory. 
Interaction energies were computed for the resulting “crystal structure” geometries as the 
energy difference between the complex and the separated monomers at the dimer 
geometry. These complexes were also subjected to full geometry optimizations to the 
nearest local minimum, and the binding energies evaluated at the B97-D/TZV(2d,2p) 
level of theory.  
 
 
 
Figure IV-2. Intermolecular coordinates used to define stacking interactions between 
aromatic amino acid side chains and nitroarenes. 
 
 
DFT computations were performed using Gaussian 09,
333
 while the CCSD(T) and 
MP2 energies were computed using Molpro.
334
 SAPT0 computations were carried out 
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using Psi4.
335
 All ab initio energies were counterpoise corrected,
336
 while the B97-D 
energies were not. 
 
Results and Discussion 
Model Stacking Interactions 
In total, 94 unique stacked dimers were located involving the four nitroarenes (1-
NO2, 2-NO2m, 2-NO2p, and 3-NO2) and the four aromatic amino acid side chains (His, 
Phe, Trp, and Tyr). The distribution of binding energies of these unique complexes are 
displayed in Figure IV-3. The number of unique complexes for each amino 
acid/nitroarene pair was rather heterogeneous, ranging from only two for His
…
3-NO2 to 
nine each for Tyr with 1-NO2 and 2-NO2m. Overall, the numbers of energy minima 
reflect the symmetry of the nitroarene, as expected, with fewer unique complexes for 2-
NO2p and 3-NO2 compared to the less-symmetric 1-NO2 and 2-NO2m. For most of the 
dimers, there is a significant spread in binding energies depending on the relative 
orienation of the two stacked sytems. 
The B97-D optimized structures of the lowest-lying complex for each amino 
acid/nitroarene pair are shown in Figure IV-4, along with CCSD(T) predicted binding 
energies. These CCSD(T) data are listed in Table III-1, along with the corresponding 
B97-D/TZVP(2d,2p) SAPT0 interaction energies. Overall, the B97-D energies are very 
strongly correlated with the CCSD(T) data (r = 0.98), lending credence to the use of this 
dispersion-corrected DFT method to optimize geometries. SAPT0 interaction energies 
are listed in Table III-1, along with the contribution of electrostatic, exchange-repulsion, 
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induction, and dispersion effects to the total interaction. The SAPT0 interaction energies 
are also very strongly correlated with the CCSD(T) binding energy data (r = 0.995), 
again supporting the use of this method to further understand these interactions. Overall, 
the SAPT data indicate that these interactions are driven by a combination of 
electrostatic and dispersion interactions. That is, removal of either of these two 
components results in very poor correlations with the total interaction energies, so both 
are vital for describing the magnitude of these non-covalent interactions. 
 
 
 
Figure IV-3. Distribution of B97-D/TZV(2d,2p) predicted binding energies for model 
stacked complexes between 1-NO2, 2-NO2m, 2-NO2p, and 3-NO2 with His, Phe, Trp, 
and Tyr side chains.  
 
 
More insight can be obtained by looking at trends in the CCSD(T) interaction 
energies for a given amino acid side chain across all four nitroarenes. For each amino 
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acid, the interaction energy gets more favorable as the number of nitro groups increases, 
accompanied by a contraction of distance between the nitroarene and amino acid side 
chain by about 0.2 Å going from 1-NO2 to 3-NO2. These data are consistent with the 
well-established tendency of nitro-substituents to enhance π-stacking interactions.309-
312,337,338
 However, the increase in interaction energy with the number of NO2-groups is 
not uniform, in contrast to results for model stacked benzene dimers.
113,339
 For example, 
the stacking interaction in 2-NO2m
…
His is 2 kcal mol
–1
 more favorable than that of 1-
NO2
…
His, yet the stacking interaction is only enhanced by 1 kcal mol
–1
 upon addition of 
the third nitro group in 3-NO2
…
His. This lack of additivity highlights the local nature of 
substituent effects in these π-stacking interactions, and the accompanying dependence of 
substituent effects on the local orientaiton of stacked rings.
119
 More precisely, the 
introduction of additional nitro groups does not always lead to the same degree of 
enhancement due to differences in available local, direct interactions between the nitro 
group and functionality on the amino acid side chain. 
The importance of local, direct interactions is also reflected in the geometries of 
these stacked dimers. In all cases, the local, direct interaction present in the 1-NO2 dimer 
is preserved in the more heavily substituted dimers. For example, the placement of the 
NO2 group directly above the NH of His in the 1NO2
…
His dimer is also present in the 
global minimum complexes of His with 2-NO2m, 2-NO2p, and 3-NO2. Similarly, the 
NO2
…
CH3 interaction present in the 1-NO2
…
Phe dimer is also present in the other Phe 
complexes. The complexes involving Trp exhibit both of these interactions, although 
orienting the NO2 group above the NH of the indole ring appears to take precedent. As a 
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result, the lowest-lying complex between 1-NO2 and Trp features this NO2
…
NH, 
whereas both this interaction and the Phe-like interaciton of the nitro group with the 
methyl group of Trp are present in the other Trp complexes. Similarly, for the Tyr 
complexes, the NO2
…
OH interaction seems to dominate the direct interaction between 
the nitro and methyl groups that appears in the more substituted cases. 
In the case of dinitrobenzene, 2-NO2m exhibits stronger interactions with all four 
amino acid side chains than does 2-NO2p. One could attribute this 1 kcal mol
–1 
energy 
difference to the lack of a molecular dipole moment in p-dinitrobenzene. However, such 
an explanation falls flat when applied to 3-NO2, which has no net dipole yet engages in 
significantly stronger interactions with the amino acid side chains than either 2-NO2m or 
2-NO2p. Similarly, 2-NO2p has no molecular dipole, yet exhibits much stronger 
interactions with the amino acid side chains than the decidedly polar 1-NO2. Instead, the 
enhanced interaction of 2-NO2m compared to 2-NO2p results from geometric effects—
the two nitro groups in m-dinitrobenzene are more ideally positioned to engage in 
favorable local, direct interactions with the key features of these four amino acids. 
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Figure IV-4. Global minimum energy structures for model stacked dimers of His, Phe, 
Tyr, and Trp amino acid side chains with 1-NO2, 2-NO2m, 2-NO2p, and 3-NO2 
optimized at the B97-D/TZV(2d,2p) level of theory. Estimated CCSD(T)/aug-cc-pVTZ 
binding energies are provided in kcal mol
–1
, while distances between ring centroids are 
given in Angstroms. 
 
 
Considering instead the interactions of a single nitroarene with each of the 
aromatic amino acids, we find that the interaction energy follow the trend Trp > Tyr > 
Phe ≈ His. The reason can be attributed to a combination of dispersion interaction and 
direct interactions between the nitro-substituents and the local dipoles associated with 
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the heteroatoms in His and Trp. For example, even though complexes with 
phenylalanine have more favorable net dispersion interactions due to the larger size of 
the ring, this favorable interaction is compensated by direct interactions between the 
nitro-substituents of the nitroarenes and the NH group of the His. Similarly, even though 
both tryptophan and tyrosine exhibit favorable direct interactions with the nitro group 
(involving the NH group for Trp, and the OH for Tyr), the total interaction energy is 
greater for tryptophan complexes due to the additional dispersion interactions enabled by 
the larger surface area of Trp compared to Tyr.  
  These data enable other comparisons among different amino acids, yielding 
additional insight into the impact of substituents on π-stacking interactions in realistic 
stacked complexes. For example, the presence of the hydroxyl group in Tyr provides a 
nearly constant 2 kcal mol
–1
 enhancement in the stacking interaction compared to Phe. 
This arises in part through weak OH
…
ON interactions, evidenced by the distortion of 
one of the nitro groups from planarity in all four of the complexes with Tyr. Moreover, 
the presence of the OH group in Tyr alters the prefered orientation of the nitroarene. 
This is most obvious for p-dinitrobenzene, which is rotated almost 90° between the Phe 
and Tyr global minimum structures; this stark difference in preferred stacking 
orientations will presumably play a role in the binding poses of nitroarenes in nitroarene 
binding sites featuring Phe vs Tyr residues. 
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Table IV-1. SAPT0/jun-cc-pVDZ, B97-D/TZV(2d,2p), and estimated CCSD(T)/aug-cc-
pVTZ interaction energies, as well as SAPT0 components for stacked dimers of His, 
Phe, Trp, and Tyr amino acid side chains and 1-NO2, 2-NO2m, 2-NO2p, and 3-NO2. 
 
 
Eelec Eexch Eind Edisp ESAPT0 EB97D ECCSD(T) 
His 1-NO2 –7.2 11.3 –1.7 –10.2 –7.7 –7.2  –6.9 
 2-NO2m –10.0 15.5 –2.8 –12.9 –10.3 –9.6  –8.9 
 2-NO2p –8.4 13.2 –2.2 –11.5 –8.8 –8.3  –7.8 
 3-NO2 –11.7 17.7 –3.9 –14.2 –12.2 –11.2  –9.9 
Phe 1-NO2 –5.7 11.0 –1.3 –11.3 –7.3 –6.4  –6.7 
 2-NO2m –8.6 14.3 –1.9 –13.9 –10.2 –8.5  –8.8 
 2-NO2p –7.7 13.4 –1.8 –13.0 –9.1 –7.6  –7.7 
 3-NO2 –10.3 16.1 –2.7 –15.2 –12.1 –10.1 –10.0 
Trp 1-NO2 –10.0 17.6 –2.5 –16.6 –11.6 –9.6  –9.4 
 2-NO2m –14.4 22.8 –3.9 –20.0 –15.6 –13.2 –12.7 
 2-NO2p –13.6 22.6 –3.8 –19.9 –14.7 –12.9 –11.6 
 3-NO2 –18.0 28.2 –6.1 –23.6 –19.6 –16.6 –15.0 
Tyr 1-NO2 –9.0 12.9 –2.0 –11.6 –9.7 –7.9  –8.5 
 2-NO2m –11.6 17.0 –2.8 –15.1 –12.5 –10.6 –10.8 
 2-NO2p –11.1 16.6 –2.6 –14.3 –11.3 –9.7  –9.6 
 3-NO2 –13.6 19.5 –3.8 –16.6 –14.5 –12.2 –11.9 
 
 
Nitroarene Binding Sites in Proteins 
The PDB contains a large number of proteins with nitroarene-containing ligands 
bound, and an analysis of these structures reveals several trends.
340
 An examination of 
the distribution of amino acid residues in the 216 nitroarene binding sites revealed that 
the following amino acids represent more than 5% of binding site residues: Phe 8%; Tyr, 
Leu 7%; and Trp, Ser, Val, Gly 6%. The importance of aromatic amino acids in 
nitroarene binding is made more apparent by considering the proportion of each of the 
aromatic amino acid side chains that are located in the binding pocket, compared to all 
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instances of these amino acids in the proteins: Trp 17% > His 11% > Tyr 10% ≈ Phe 
10%.  
Of the 216 crystal structures containing nitroarene ligands, 191 have nearby 
aromatic amino acids. From these, we extracted 65 unique stacking interactions between 
an aromatic amino acid and nitroarenes that was not part of fused rings (see Table IV-2). 
These stacking complexes contain predominantly nitrophenyl rings, although seven 
structures contain m-dinitrophenyl groups. Trp residues are the most well-represented of 
the aromatic amino acid side chains in these stacking interactions, being involved in 23 
of the 65 (35%). This is perhaps unsurprising in light of the model complexes studied 
above, which indicate that Trp engages in far stronger stacking interactions with 
nitroarenes than any of the other aromatic amino acid side chains. Trp is followed by 
Phe and Tyr residues, which are involved in 20 (31%) and 17 (26%) of the stacking 
interactions, respectively. His is far less commonly found among these stacked 
complexes in the PDB, appearing only five times (8%). This was initially somewhat 
surprising, since in the model complexes, stacking interactions between nitroarenes and 
the His sidechain is of similar strength to Phe, and not much weaker than Tyr. However, 
the small size of the imidazole ring of His, as well as the possibility of strongly favorable 
NH
…π interactions, result in His having a greater tendency to engage in T-shaped 
interactions over π-stacking interactions when complexed with an arene. Such 
geometries were excluded from our analysis of the PDB structures, and likely account 
for the dearth of π-stacking interactions of His with nitroarenes in the analyzed 
nitroarene binding sites. 
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Figure IV-5. B97-D/TZV(2d,2p) predicted interaction energies for stacked dimers of 
nitroarenes with aromatic amino acid side chains (His, Phe, Trp, and Tyr) in the crystal 
structure geometry (‘Cryst’, blue lines) and the binding energies for the corresponding 
relaxed gas-phase energy minima (‘Opt’, red lines).  
 
 
We have quantified the stacking interactions present in these binding sites at the 
B97-D/TZV(2d,2p) level of theory. Table IV-2 lists computed interaction energies for 
the crystal structure geometries, as well as the binding energies of the corresponding 
local minima resulting from full optimizations of these nitroarene-amino acid dimers. 
These data are plotted in Figure IV-5. The trend in energies both in the crystal structure 
geometries and the corresponding relaxed gas-phase dimers follow the results for the 
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model stacked dimers. That is, stacking interactions in nitroarene binding sites follow 
the trend Trp > Tyr > Phe ≈ His.  
There is often significant deviation from the interaction energies in the crystal 
structure geometries and the binding energies of the corresponding gas-phase minima. 
For example, the stacking interaction between His and the nitroarene in 1NO3 is barely 
favorable (–0.3 kcal mol–1), whereas the corresponding relaxed structure has an 
interaction energy of –5.7 kcal mol–1. Other cases are less extreme, although similarly 
notable. For example, 3MK0 exhibits a stacking interaction between a Tyr side chain 
and a nitroarene, which is predicted to contribute –3.4 kcal mol–1 to the binding. 
However, upon relaxation, this resulting binding energy of –8.7 kcal mol–1 is more than 
60% stronger. These differences mirror those found by Tschumper et al.
237,325
 in their 
studies of stacking interactions of Tyr and Phe side with adenine in protein complexes, 
and could be due to a number of factors. The most likely contributor is the impact of 
other binding site residues as well as the additional components of the nitroarene ligand 
that were excised in these model complexes. The binding in the protein will obviously 
reflect the most favorable net interaction between the entire ligand and protein (not to 
mention entropic effects), whereas we are only considering the stacking interactions with 
the nitroarene component. Finally, in the case of His residues, we have assumed the most 
common protonation state, whereas a number of protonation states could be prevalent in 
the protein.  
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Table IV-2. B97-D/TZV(2d,2p) interaction energies (kcal mol
–1
) for stacked dimers of 
1-NO2 and 2-NO2m with His, Phe, Trp, and Tyr amino acid side chains found in the 
PDB. The interaction energies in the crystal structure geometry (Cryst) are provided, 
along with the binding energies of the corresponding gas-phase optimized energy 
minima (Opt).
a 
Structure 
Amino 
Acid Cryst Opt Structure 
Amino 
Acid Cryst Opt 
1NO3 His –0.3 –5.7 2PDJ Trp –8.2 –8.6 
2Q95 His –2.7 –5.8 2PDP Trp –7.7 –8.8 
3CHT His –9.9 –7.8 2PDU Trp –8.2 –8.8 
3OJK His –4.3 –6.6 2PZN Trp –8.2 –8.8 
43CA His –5.7 –6.4 2V96 Trp –7.6 –8.3 
1AI5 Phe –4.3 –7.1 2VCZ Trp –8.0 –8.6 
1GLQ Phe –4.3 –7.6 2WGZ Trp –6.6 –9.2 
1JMZ Phe –3.2 –6.1 2WGZ Trp –7.0 –10.8 
1LS6 Phe –4.7 –6.4 2XEFa Trp –13.6 –13.9 
1LS6 Phe –4.4 –6.0 3ABX Trp –5.4 –10.3 
1PX0 Phe –6.4 –7.4 3AIR Trp –9.9 –10.9 
1RMH Phe –4.7 –6.8 3M64 Trp –8.1 –8.8 
1T47 Phe –5.4 –8.8 3MC5 Trp –8.1 –8.8 
1T47 Phe –5.0 –8.4 3PQTa Trp –6.6 –14.8 
1T47 Phe –5.8 –10.2 4A3Ha Trp –7.9 –13.6 
1T47 Phe –4.6 –5.4 1YEK Tyr –3.5 –8.6 
1V9T Phe –4.8 –6.9 18GSa Tyr –6.7 –10.4 
1VBT Phe –4.9 –6.8 1OAUa Tyr –5.2 –10.5 
1ZMT Phe –5.9 –7.2 1RD4 Tyr –5.5 –8.1 
2GGX Phe –4.7 –6.6 1XWKa Tyr –5.5 –9.9 
2OAC Phe –4.3 –6.6 2D20 Tyr –4.4 –7.2 
2OAD Phe –4.5 –6.6 2D20 Tyr –3.6 –6.1 
2V96 Phe –3.5 –7.3 2NRU Tyr –3.9 –7.5 
3G4G Phe –5.1 –7.8 2OAD Tyr –4.2 –7.3 
3O76 Phe –4.1 –6.6 2WNB Tyr –4.8 –9.7 
1H2J
a
 Trp –7.8 –13.4 2WNF Tyr –4.6 –9.7 
1OAU
a
 Trp –10.5 –11.4 2Y59 Tyr –5.6 –6.5 
1RMH Trp –7.1 –10.2 2XAP Tyr –6.3 –8.3 
1VAH Trp –5.1 –10.8 3LM1 Tyr –3.7 –6.1 
1VBT Trp –6.7 –8.0 3MK0 Tyr –3.4 –8.7 
1YEK Trp –7.8 –9.1 3MK1 Tyr –3.1 –7.2 
2IKJ Trp –7.9 –8.8 3O76 Tyr –5.4 –6.9 
2PDC Trp –8.2 –8.8     
a
 Complex involves 2-NO2m 
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On the other hand, the computed interaction energies for some of the complexes 
extracted from crystal structures are strikingly similar to those of gas-phase optimized 
dimers, suggesting that in these cases the binding is dominated by these π-stacking 
interactions. For example, the interaction between Trp and the m-dinitrophnyl ring in 
2XEF (–13.6 kcal mol–1, see Figure IV-1) is nearly identical to that in the corresponding 
relaxed gas-phase complex (–13.9 kcal mol–1). Similarly, the stacking interaction 
between the m-dinitrophenyl ring and the Trp in 1OAU (–10.5 kcal mol–1) is about 90% 
of the strength in the corresponding gas-phase energy minimum (–11.4 kcal mol–1). On 
the other hand, the interaction of this same nitroarene with the Tyr residue in 1OAU (–
5.4 kcal mol
–1
, see Figure IV-1) is only about half the strength of the corresponding 
relaxed complex (–10.5 kcal mol–1).  
 
Summary and Concluding Remarks 
Nitroarene binding sites abound in proteins, and have been widely exploited in a 
number of therapeutic contexts.
290-308
 However, despite the prevalence of these binding 
sites and their utility, little is known about the non-covalent interactions that drive the 
binding of nitroarenes by proteins. We have presented high-accuracy computational 
binding energies for model stacked complexes of nitroarenes with the amino acid side 
chains His, Phe, Trp, and Tyr. The data reveal that nitroarenes engage in strong π-
stacking interactions with these aromatic amino acid side chains, with gas-phase 
interaction energies ranging from –6.7 kcal mol–1 (Phe with nitrobenzene) to –15.0 kcal 
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mol
–1
 (Trp with 1,3,5-trinitrobenzene). Overall, Trp engages in the strongest π-stacking 
interaction, followed by Tyr.  
Unlike model stacked benzene dimers, we find that the impact of multiple nitro 
groups are not additive in complexes with His, Phe, Trp, and Tyr. This is attributed to 
the impact of local, direct interactions between the nitro groups and substituents and 
heteroatoms in the amino acid side chains. Further evidence of the importance of local, 
direct interactions in these stacking interactions comes from examination of the 
structures of the lowest-lying complexes for each amino acid/nitroarene pair. 
In order to gain further insight into the π-stacking interactions in nitroarene binding 
sites of proteins, we have mined the PDB. Of 216 crystal structures that contain 
nitroarenes, 191 contain aromatic amino acids within 5 Å of the nitroarene. Of the 
binding sites containing aromatic amino acids, many exhibit clearly-defined π-stacking 
interactions between aromatic amino acids and the nitroarene component of the ligands. 
DFT computations applied to 65 such π-stacking complexes indicate that such 
interactions contribute significantly to the binding of the nitroarene. The resulting data 
should provide insight into the factors that lead to strong nitroarene binding, which 
should aid in both the identification of unrecognized nitroarene binding sites and the 
more effective exploitation of these interactions in biological applications. 
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CHAPTER V  
STACKING INTERACTIONS BETWEEN 9-METHYLADENINE AND 
HETEROCYCLES COMMONLY FOUND IN PHARMACEUTICALS 
 
Introduction 
π-stacking interactions are central to many areas of chemistry, including the 
binding of ligands to proteins and nucleic acids.
72,341,342
 Harnessing such interactions lies 
at the heart of drug design.
343,344
 In this context, understanding π-stacking interactions 
involving heterocycles is of paramount importance, because heterocyclic fragments 
abound in drugs and bioactive natural products.
345-352
 Model π-stacking interactions 
involving heterocycles have been studied both experimentally
353-356
 and 
theoretically,
357,358
 with the primary aim of unraveling the many factors that control the 
strength and preferred orientation of these interactions. There have been numerous 
computational studies
359-367
 of non-covalent interactions involving pyridine as a model 
N-heterocycle, building on the seminal work on the benzene-pyridine and pyridine-
pyridine dimers by Sherrill and coworkers.
368
 Stacking interactions of other six-
membered N-heterocycles (pyrimidine, triazine, tetrazine, etc.),
369-372
 as well as 
thiophene and benzothiophene, pyrrole, imidazole, indole, and larger bioactive 
molecules, have also been investigated computationally.
373-379
  
Recently, Huber and co-workers
379
 presented a comprehensive computational 
study of stacked dimers of benzene with 5- and 6-membered aromatic heterocycles 
found in small drug-like molecules. Ultimately, they concluded that even though 
 77 
 
dispersion interactions are a significant driver of these stacking interactions, electrostatic 
effects play a key role in determining the preferred orientation of a given stacked dimer. 
Moreover, in accord with general guidelines for stacking interactions in drug design,
343
 
Huber and co-workers showed
379
 that there was a correlation between the molecular 
dipole moments of the heterocycles and the predicted stacking interaction with benzene. 
On the other hand, Gellman et al.
380,381
  previously emphasized the importance of local 
dipole moments
103,104,382-384
 in understanding heterocycle stacking, as well as the 
unreliability of analyzing stacking interactions in terms of molecular dipoles.
385
 This 
echoes our work on substituent effects in π-stacking interactions,78,386-392 which can be 
understood in terms of the interaction of the local dipole moment associated with the 
substituent and the electric field of the other ring,
390
 as well as the seminar model of 
heterocycle stacking interactions from Hunter and Sanders.
393
 More generally, these 
effects can be understood in terms of direct electrostatic interactions between functional 
groups on the opposing rings. 
 Despite progress in understanding π-stacking interactions involving heterocyclic 
rings,
368-379
 the rational design of heterocycle-containing molecules that maximize π-
stacking interactions with a given aromatic group remains a challenge. A number of 
studies have been performed to identify common heterocyclic fragments within drug-
like and bioactive molecules.
394,395352
  For example, Broughton and Watson
394
 mined 
heterocyclic motifs found in drugs that have reached Phase II clinic trial or later stages, 
reporting the 30 most frequently-identified heterocycles with good absorption, 
distribution, metabolism, excretion and toxicity (ADMET) characteristics for drug 
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design. Ertl and coworkers
395
 analyzed an expansive virtual library of heteroaromatic 
scaffolds and investigated structural, bioactivity, and quantum mechanical properties of 
these molecules. Six heterocyclic fragments with fused rings were found to be most 
well-represented in bioactive molecules. Finally, Vitaku and coworkers
352
 analyzed 
nitrogen heterocycles by exploring their structural diversity and substitution patterns, 
identifying 25 heterocycles that were found to be most commonly utilized among U.S. 
FDA approved pharmaceuticals.  
 
 
 
Figure V-1. Structures of telithromycin (a) and CEM-101 (b), as well as CEM-101 in 
the binding site of E. Coli ribosome (PDB ID: 4WWW). 
 
 
Interactions of heterocycles with aromatic amino acid side chains and nucleic 
acids abound in drug binding sites.
396-401
 For example, the Andrade group has a long-
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standing interest in ketolide antibiotics,
402-406
 which feature an extended heterocyclic 
alkyl-aryl side chain attached to the macrocycle (see Figure V-1a)
407,408
 and exhibit 
tighter binding to the ribosome compared to previous classes of macrolides.
409
 Despite 
the excellent activity of telithromycin against many macrolide-resistant bacteria,
410
 the 
adverse effects and safety concerns associated with telithromycin led to the U.S. FDA 
narrowing its approved clinical uses.
411
 The search for newer ketolides with fewer side 
effects continues, and Andrade and coworkers
402-406
 previously synthesized 4-desmethyl 
telithromycin, 4,8-didesmethyl telithromycin, 4,10-didesmethyl telithromycin, and 
4,8,10-tridesmethyl telithromycin in order to explore structure-activity relationships.  
 
 
Chart V-1. Five and six-membered heterocycles. 
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A potential alternative means of tuning the activity of telithromycin is to change 
the alkyl-aryl side chain. For example, the structure of solithromycin (formerly known as 
CEM-101), which is now undergoing Phase 3 clinical development for the treatment of 
community-acquired bacterial pneumonia (CABP), urethritis and other infections,
412
 
differs from that of telithromycin in that the alkyl-aryl side chain contains triazole and 
alinine groups (see Figure V-1b). This side chain engages in well-defined π-stacking 
interactions with the uracil-adenine pair (A752 and U2609) in the binding site of the E. 
Coli ribosome (see Figure V-1c).
412
 More precisely, the NH2 of the aniline hydrogen 
bonds with the ribose backbone of A752, the triazole stacks with U2609, and the aniline 
fragment stacks with A752. However, due to the lack of a comprehensive understanding 
of π-stacking interactions involving heterocycles, it is not apparent what heterocycles 
can replace this aniline to provide enhanced stacking with the adenine. 
Motivated by a desire to explore derivatives of CEM-101 that maximize π-
stacking interactions with A752, herein we provide a computational study of model 
stacking interactions between 9-methyladenine and a set of heterocycles commonly 
found in pharmaceuticals (see Charts V-1 and V-2). The primary aim was to delineate 
the structural features that lead to the most favorable stacking interactions with 
adenosine, in order to guide the rational design of pharmaceuticals expected to engage in 
such interactions in the binding site. 
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Chart V-2. Fused heterocycles. 
 
 
 
Theoretical Methods 
A representative collection of 46 heterocycles (see Charts V-1 and V-2) were 
selected to assess their propensity to form stacked dimers with 9-methyladenine as a 
mimic of adenosine. This set of heterocycles includes the conjugated systems identified 
by Vitaku and coworkers
352
, as well as Broughton and Watson,
394
 from their analyses of 
the structures of popular pharmaceuticals. Also included are various analogs of these, 
including structural isomers, isoelectronic congeners, etc. Although some of these other 
rings are not realistic as drug fragments due to lack of bioavailability or stability issues, 
whereas others are not the tautomer expected to be present under biological conditions, 
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they all serve to provide a more compehensive view of the heterocyclic features that lead 
to highly favorable π-stacking interactions with 9-methyladenine. This set of 
heterocycles has been divided into two main categories: five- and six-membered 
monocyclic species (Chart V-1) and heterocycles with two and three fused rings (Chart 
V-2).  
 
 
 
Figure V-2. (a) Schematic representation of the nine starting positions of the centroid of 
each heterocycle above the face of 9-methyladenine; (b) for each of these nine positions 
we considered six relative orienations of each heterocycle (pyridine used here as an 
example), for 54 total initial dimer geometries for each heterocycle. 
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The binding energy between each of these 46 heterocycles and 9-methyladenine 
was computed in the gas phase at the ωB97X-D/def2-TZVPP level of theory.413,414  
ωB97X-D, when paired with a triple-ζ basis set, was shown by Huber and co-workers379 
to provide robust predictions of stacked dimers of heterocycles with benzene. This level 
of theory has also been shown to provide accurate non-covalent binding energies for a 
wide range of model non-covalent complexes.
413,415-417
 Although these gas-phase 
computations neglect differences in the desolvation costs of the different heterocycles, 
the present results should lay the groundwork for more detailed studies of the binding of 
these fragments in more realistic environments. Geometry optimizations were first 
carried out at the B97-D/def2-TZVPP level of theory.
265,266
 To locate all stacked dimer 
configurations, we systematically searched over different relative positions and 
orientations of each heterocycle with 9-methyladenine (see Figure V-2). In particular, 54 
initial stacked geometries were constructed for each heterocycle by considering nine 
initial positions of the heterocycle above the face of 9-methyladenine (see Figure V-2a), 
with the heterocycle located 3.6 Å above and parallel to the molecular plane of 9-
methyladenine. At each of these nine positions, we considered six equally-spaced 
relative orientations of the heterocycle (e.g. see Figure V-2b). All of these initial 
structures were optimized to the nearest energy minimum. Unique optimized complexes 
were identified as those for which the root mean square deviation (RMSD) exceeded 0.5 
Å with all other structures. Geometry optimizations of many of these structures resulted 
in edge-to-edge hydrogen-bonding arrangements, which were eliminated. In the case of 
heterocycle 12, we were unable to locate any stationary point corresponding to a stacked 
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configuration with 9-methyladenine; instead, these two molecules had an overwhelming 
tendency to engage in hydrogen-bonding interactions. In total, 268 unique stacked 
complexes were identified. Gas-phase ωB97X-D/def2-TZVPP413,414 single point 
energies were then carried out at all unique optimized stacked dimer geometries. Binding 
energies were evaluated at this level of theory as the difference in energy between the 
optimized dimers and the optimized isolated monomers. All computations were carried 
out using Gaussian09.
333
 
 
Results and Discussion 
For each heterocycle, numerous stacked energy minima were located, 
corresponding to different relative orientations and positions of the heterocycle above 
the face of 9-methyladenine. The overall distributions of binding energies for each 
heterocycle are plotted in Figures V-3 and V-4. All of the complexes considered are in a 
stacking arrangement (i.e. roughly parallel orientations with a significant degree of 
overlap); however, many of the heterocycles engage in additional interactions with 9-
methyladenine. This includes CH/π and NH/π interactions, in which the edge of one ring 
is directed toward the face of the other. Moreover, the strengths of the π-stacking 
interactions are modulated by direct interactions
78,386-392
 between functional groups on 
the heterocycle and the 9-methyladenine. These direct interactions are pivotal in 
determining the preferred orientation of the stacked rings, and can be understood as 
arising from the heterogeneous distribution of charge within these heterocycles.
380,381
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Below, we will focus primarily on the global energy minimum complex for each 
heterocycle, which are depicted in Figures V-5 and V-6. 
In general, the larger rings (29 - 46) exhibited a far greater number of unique 
stacked energy minima than the smaller rings (1 - 28). In particular, whereas the small 
rings had, on average, 3.4 unique complexes, the larger rings had an average of 9.6 
unique configurations. Similarly, many of the smaller rings exhibited only one or two (or 
even zero, in the case of 12) unique stacked orientations, while there are at least four 
unique dimers for all of the larger heterocycles, many of which exhibit at least ten 
unique structures. Finally, even though the binding energies of the larger rings were 
typically more favorable, many of the smaller rings show substantial binding energies. 
 
 
 
Figure V-3. Distribution of predicted binding energies (kcal mol
–1
) for stacked dimers 
of 9-methyladenine with heterocycles 1-28. For 12, no stacked energy minima were 
identified at the B97-D/def2-TZVPP level of theory. 
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Starting with the 5-membered rings (1-16), we see a considerable spread in 
binding energies among the most favorable complexes for each heterocycle, ranging 
from –6.1 kcal mol–1 for 2 to –10.9 kcal mol–1 for 11. Results for the triazoles (10-13) 
are particularly notable, revealing several trends that are seen again for the larger 
heterocycles. For example, 11 (4H-1,2,4-triazole), with a predicted binding energy of –
10.9 kcal mol
–1
, shows the most favorable binding energy of all 5-membered rings. For 
1H-1,2,3-triazole (12), on the other hand, no stacked energy minima were located, 
whereas its tautomer 2H-1,2,3-triazole (13) exhibits a modestly favorable π-stacking 
interaction of –7.3 kcal mol–1. It is important to note that this binding energy is actually 
less favorable than that predicted for pyrrole (1), highlighting the general trend that the 
incorporation of additional nitrogen atoms does not always lead to stronger stacking 
interactions. Finally, the predicted binding energy for 10 is 2 kcal mol
–1
 less favorable 
than for its tautomer 11.  
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Figure V-4. Distribution of predicted binding energies (kcal mol
–1
) for stacked dimers of 
9-methyladenine with heterocycles 29-46. 
 
 
All of these data highlight the sensitivity of heterocycle stacking interactions to 
not only the regioisomer but also the tautomer that is present. This implies that the 
tautomer present in a given binding site could differ from that favored in solution, as 
long as the non-covalent interactions with 9-methyladenine can compensate for the 
energetic cost of forming a less favorable tautomer. The sensitivity to the tautomer 
present also extends to tautomeric tetrazoles 14 and 15, for which the predicted binding 
energies differ by 2.4 kcal mol
–1
. 
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Figure V-5. Global minimum energy stacked dimers of 9-methyladenine and the 
heterocycles 1-28. ωB97X-D/def2-TZVPP predicted binding energies are provided in 
kcal mol
–1
. For 12, no stacked energy minima were identified at this level of theory. 
 89 
 
 
Figure V-6. Global minimum energy stacked dimers of 9-methyladenine and the 
heterocycles 29-46. ωB97X-D/def2-TZVPP predicted binding energies are provided in 
kcal mol
–1
. 
 
 
In the case of 11, the stacking interaction is enhanced by favorable direct 
interactions between the NH group of the triazole and a ring-nitrogen of 9-
methyladenine, as well as between a ring nitrogen of 11 and the methyl group of 9-
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methyladenine. Notably, the former interaction is not a conventional NH-donated 
hydrogen bond (the N
…
H-N angle is less than 112°). Instead, this interaction is best 
described as the interaction of the local dipole moment associated with the NH group 
and the electric field of 9-methyladenine. The electric field in the region above the ring 
nitrogen will be dominated by the local dipole created by that nitrogen and the 
associated lone pair, similar to that observed above the nitrogens of triazine.
390
  The 
latter interaction, occurring between a nitrogen and a decidedly non-polar CH group, is 
presumably driven largely by dispersion interactions. Notably, both of these interactions 
are present in many of the minimum energy complexes shown in Figures V-5 and V-6, 
and appear to be the primarily factors impacting the preferred orientation of stacked 
complexes of 1 - 46 with 9-methyladenine. 
Comparing pyrrole (1), furan (2), and thiophene (3), binding energies follow the 
trend 1 > 3 > 2. In the case of 1, the enhanced π-stacking appears to stem from the ability 
of pyrrole to engage in a strained hydrogen-bonding interaction between the NH of the 
pyrrole and the exocyclic NH2 group of 9-methyladenine. This strained NH
…
N 
interaction also appears in the lowest-lying stacked dimers for imidazole (8) and 
pyrazole (9), which engage in stronger stacking interactions than their sulfur-analogs 
thiazole (7) and isothiazole (6). However, the tendency of sulfur-based heterocycles to 
provide more favorable π-stacking interactions than oxygen-based rings is not 
transferable to 5-membered rings with multiple heteroatoms. For example, comparing S-
containing rings 6 and 7 with their oxygen analogs (4 and 5), we see that O-containing 
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rings engage in stacking interactions that are equal to or more favorable than the S-
containing systems.  
The six-membered rings (17-28) show a slightly narrower range of predicted 
binding energies. The rings examined primarily comprise benzene and the isoelectronic 
azines that result from the incorproation of between one and four nitrogens into the ring. 
In general, the nitrogen-containing heterocycles have more favorable π-stacking 
interactions with 9-methyladenine compared to benzene (17, –7.0 kcal mol–1). For 
example, the single nitrogen atom in pyridine results in a 1.7 kcal mol
–1
 enhancement of 
the binding energy, compared to benzene. However, the incorporation of a second 
nitrogen does not always lead to further enhancement of the interaction. For example, 
1,4-pyrazine (19) and 1,3-pyrazine (20) engage in π-stacking interactions with 9-
methyladenine that are slightly weaker than that of pyridine. Indeed, only 1,2-pyrazine 
(21) is predicted to provide greater stacking compared to pyridine. The triazines (22-24) 
show similar trends, with 1,3,5-triazine (22) leading to reduced stacking compared to 
pyridine, but the less-symmetric triazines (23 and 24) leading to more favorable stacking 
interactions than predicted for pyridine. The most favorable interaction for the triazines 
is predicted for the 1,2,3-isomer, 24. For the tetrazines (25 - 27), only 1,2,3,4-tetrazine 
(27) provides a more favorable stacking interactions than pyridine. As seen with 11, 
many of the six-member N-heterocycles display interactions between a ring-nitrogen and 
the methyl group of 9-methyladenine, again suggesting that this is an important 
interaction. Finally, we note that pyrimidine (28) engages in much more favorable 
stacking interactions with 9-methyladenine than any of the azines (–12.2 kcal mol–1). 
 92 
 
Turning next to the fused heterocycles (29 - 46), we see that these engage in 
much stronger π-stacking interactions with 9-methyladenine, on average, with predicted 
binding energies ranging from –10.1 kcal mol–1 to –13.9 kcal mol–1. Presumably, this 
arises from the greater surface area contact with 9-methyladenine, which will lead to 
more stabilizing dispersion interactions. However, even though the fused heterocycles 
exhibit stronger stacking interactions than the monocyclic heterocycles, there is no clear 
pattern with regard to the three-ring fused heterocycles and those with only two-rings. 
Any gain due to increased surface area quickly dissipates after the size of the heterocycle 
is comparable to that of adenine.  
As with the small rings, the predicted stacking energies are sensitive to the 
distribution of heteroatoms within each ring. For instance, indole (29) and isoindole (30) 
exhibit stronger stacking interactions than indolizine (31). In the former case, a strained 
NH
…
N hydrogen bonding interaction leads to indole deviating significantly from a 
parallel stacked arrangement. Isoindole (30), on the other hand, exhibits a nearly parallel 
configuration that is further enhanced by the unconventional NH
…
N interaction seen for 
many of the smaller N-heterocycles. Similarly, 1,8-naphthyridine (33) exhibits stronger 
stacking interactions than quinazoline (34) due to the presence of two N
…
H3C 
interaction in the former case but only one in the latter case. The minimum energy 
complexes of 38 and 39 also exhibit this interaction. Overall, many of these larger 
heterocycles exhibit the same local, direct interactions as their smaller analogs. For 
example, the five-membered ring in 37 is in nearly the same orientation as seen for 8. 
Similarly, the preferred stacking pose of 32 is similar to that of 18. However, the 
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preferred orienation of the fused heterocycles can not always be predicted based on the 
preferred orientation of the component rings. For instance, the pyrimidine ring in 
quinazoline (34) is shifted significantly compared to pyrimidine itself (20). 
With regard the broader trends, all of the heterocycles showed a marked 
sensitivity to orientation relative to 9-methyladenine, as indicated by the wide spread in 
predicted binding energies seen in Figures V-3 and V-4. This is perhaps unsurprising, 
given the established importance of electrostatic effects in heterocycle stacking and the 
heterogeneous distribution of charge around these rings.
373-379
 However, this sensitivity 
has important implications for understanding stacking interactions in drug binding sites. 
In particular, even though a given heterocycle might engage in strong π-stacking 
interactions with 9-methyladenine, this might require a relative orientation that is not 
compatible with a given binding site. For instance, 1,2,3-triazine (24) is capable of 
engaging in strong π-stacking interactions with 9-methyladenine, with a predicted 
binding energy of –9.9 kcal mol–1. However, this is only true for the orientation pictured 
in Figure V-5, in which the nitrogens of the triazine can interaction with the methyl 
group of the 9-methyladenine. In the other minimum energy orientation, the predicted 
binding energy is reduced to –7.0 kcal mol–1, which is far weaker than many of the other, 
similarly-sized heterocycles. Similar observations hold for larger rings like 41, for which 
the global minimum energy structure binds far more strongly than the next lowest-lying 
energy minimum.  
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Figure V-7. Predicted binding energies (kcal mol
–1
) for the global minimum energy 
stacked dimer of 9-methyladenine with heterocycles 1-46 versus the molecular dipole 
moments (in Debye) of the heterocycles. The slope and r
2
 values apply to the best-fit 
lines for the small rings (1-28) and large rings (29-46) separately. 
 
 
The above discussion has been cast primarily in terms of local, direct 
interactions, which we have shown to provide a more robust description of substituent 
effects in π-stacking intreactions.78,386-392 However, given the common practice of 
discussing heterocycle stacking in terms of molecular dipole moments,
343,379
 the ability 
of molecular dipole moments to predict the binding energies of these stacked complexes 
with 9-methyladenine was also considered. Overall, the molecular dipole moments of the 
heterocycles are poorly correlated with the total binding energies for the lowest-energy 
stacked complex for each heterocycle (see Figure V-7). However, considering only the 
small heterocycles (1-28), there is a good correlation (r
2
 = 0.78) and in these cases dipole 
moments provide at least a qualitative predictor of π-stacking strengths with 9-
methyladenine in these cases. This echos the recent work of Huber et al.
379
 regarding 
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stacking interactions of small heterocycles with benzene. Moreover, for nearly all of the 
small heterocycles, the predicted global minimum energy stacked dimer corresponds to 
an orientation that features oppositely-oriented molecular dipoles (for examples, see 
Figure A-1 in Appendix). However, in the case of the fused heterocycles (29-46), there 
is essentially no correlation with the molecule dipole moment (r
2
 = 0.18, see Figure V-
7). This inability of molecular dipole-dipole interactions to predict the strength of π-
stacking interactions for larger systems is unsurprising, because the multipole expansion, 
of which the dipole-dipole interaction is the leading term, will become less reliable as 
the size of the interacting systems grows with respect to the intermolecular distance. 
Thus, although the leading dipole-dipole term provides a reliable predictor of stacking 
interactions for small heterocycles, these interactions are more readily understood in 
terms of local, direct interactions of the functional groups on the two stacked systems 
(or, similarly, in terms of local dipole moments as championed by Gellman and co-
workers).
380,381
   
 
Summary and Concluding Remarks 
Stacking interactions of 9-methyladenine with 46 heterocycles representative of 
common fragments of drug-like molecules were predicted at the ωB97X-D/def2-
TZVPP//B97-D/def2-TZVPP level of theory. Overall, 268 unique stacked complexes 
were identified, exhibiting a broad range of predicted binding energies. Many of these 
interactions were highly favorable, and the introduction of heterocycles into the alkyl-
aryl side chain of CEM-101 analogs should provide a powerful means of tuning its 
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binding affinity by modulating the stacking interaction of this group with A752 (see 
Figure V-1c). The broad range of predicted binding energies for each of the heterocycles 
highlights the impact of relative orientations on the stacking of heterocycles, with 
important implications for drug design. 
Overall, larger heterocycles engage in stronger π-stacking interactions than their 
smaller analogs. However, many of the features that impact the preferred orientation of 
the smaller rings are mirrored in the larger systems, leading to the identification of 
several structural features that lead to  strong stacking interactions of heterocycles with 
9-methyladenine. Most notably, heterocycles with NH groups exhibit strong π-stacking 
interactions with 9-methyladenine, presumably because of the favorable interaction 
between this NH group and the ring-nitrogens of adenine. Unlike a conventional NH
…
N 
hydrogen bond, in this direct NH
…
N interaction the NH
…
N angle approaches 90°. 
Similarly, unconventional N
…
H3C interactions occur in many of the lowest-lying 
complex for each heterocycle, suggesting this a second key factor that enhances π-
stacking interactions of N-heterocycles with 9-methyladenine. 
For all of the heterocycles considered, the distribution of heteroatoms within 
each ring as well as the particular tautomer considered has a profound impact on 
predicted stacking interactions. One implication is that the tautomer present in the bound 
state could actually differ from that favored in solution. Although molecular dipole 
moments can provide a qualitative predictor of the strengths of stacking interactions of 
small heterocycles (5- and 6-membered rings) with 9-methyladenine, they are 
uncorrelated with the predicted binding energies of the larger, fused heterocycles. 
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Instead, both the preferred orientations and stacking interactions can be more readily 
explained in terms of local, direct interactions between functional groups on the two 
interacting systems. 
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CHAPTER VI  
EFFECTS OF Π-STACKING INTERACTIONS ON THE PKA’S OF IONIZABLE 
AMINO ACID SIDE CHAINS 
 
Introduction 
The protonation state of individual amino acids contributes to the structure, 
function, solubility, and stability of a protein,
418-427
 and can impact everything from the 
catalytic activity of enzymes to the tendency of drugs to bind. Therefore, determining the 
pKa values of ionizable amino acids is indispensable in protein science. Aspartic acid 
(Asp), glutamic acid (Glu), cysteine (Cys), tyrosine (Tyr), histidine (His), lysine (Lys), 
and arginine (Arg) are the seven ionizable amino acid side chains, and their protonation 
state has great impact on the net charge and overall pKa of proteins (Chart VI-1). Among 
these seven ionizable side chains, Asp, Glu, Tyr and Cys are neutral at pH values below 
their pKa and negatively charged above the pKa, while Arg, His, and Lys side chains are 
positively charged for pH values under their pKa and neutral at pH values above their 
pKa. 
The pKa values of folded proteins can be measured via nuclear magnetic 
resonance (NMR), potentiometric titration based on small peptide models, and other 
indirect methods,
422,428-432
 which has led to a plethora of experimental pKa values for 
different amino acid side chains. Ionizable groups buried deeply in folded proteins often 
show large deviations from the intrinsic pKa values of the isolated side chains,
433
 and 
changes in pKa values can be both positive and negative.
429,432,434-440
 Average pKa values 
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for the ionizable amino acid side chains are presented in Chart VI-1, along with the 
standard deviation in values over a set of proteins.
441
 As can been seen from these data, 
pKa values typically vary by 1-2 pKa units, although much larger changes are possible.
441
  
These pKa changes are typically attributed to three primary effects: dehydration (Born 
effect), charge-charge interaction (Coulombic interactions), and charge-dipole 
interactions (hydrogen bonds).
430,441-447
  
 
 
Chart VI-1. Molecular structures of amino acids considered here. The side chains were 
modeled as the red portion of each structure, up to and including Cβ. For the ionizable 
amino acid side chains, the average pKa values are provided along with typical ranges.
441
 
 
 
Despite progress toward the accurate prediction of absolute and relative amino 
acid pKa values,
448-450
 the influence of individual non-covalent interactions on pKa 
values, particularly those involving aromatic amino acid residues, are not well 
understood. We are particularly interested in cases where a neighboring aromatic residue 
forms close contact with an ionizable residue through π-stacking and XH/π 
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interactions.
268-270,451-453
 These types of interactions have been shown to be strong 
stabilization forces in cases of protein-DNA complexes and protein-ligand complexes.
454
 
Upon ionization, the strength of these non-covalent interactions will change significantly. 
The resulting difference in the ability of the aromatic amino acid side chains to bind the 
protonated and deprotonated forms of the ionizable side chain could lead to potentially 
large changes in pKa. 
Motivated by the tabulated experimental pKa ranges of each ionizable side chain 
by Grimsley et al.,
441
 we systematically explored the impact of π-stacking interactions 
between ionizable residues and the aromatic residues Phe, Tyr, Trp, and His using 
simplified model side chains. The results shed light on the impact of individual side 
chain interactions on pKa-values, and the trends unveiled here could be used as a guide 
to understand environmental impacts on the pKa’s of ionizable groups in proteins. 
 
Theoretical Methods 
Changes in pKa values (ΔpKa) for the seven ionizable amino acid side chains 
upon complexation with aromatic amino acid side chains were predicted. The amino acid 
side chains were modeled by replacing the backbone and Cβ with a methyl group (see 
Chart VI-1). For each ionizable group, we first determined all possible stacked 
complexes with with the aromatic residues Phe, Tyr, Trp, and His. Geometry 
optimizations were carried out at the B97-D/def2-TZVPP level of theory
68,455
 in implicit 
water using the PCM model.
456,457
 To locate all stacked complexes, we systematically 
searched over different relative positions and orientations of each ionizable group 
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stacked with aromatic residue (See Figure VI-1a). In particular, for each amino acid pair 
we constructed 54 initial stacked geometries by considering nine initial positions of the 
ionizable side chain above the face of aromatic residue, with the ionizable residue 
located 3.6 Å above and parallel to the molecular plane of aromatic side chain. At each 
of these nine positions, we considered six equally-spaced relative orientations of the 
ionizable group (see Figure VI-1b). All of these initial protonated structures were 
optimized to the nearest energy minimum. Many of these complexes optimized to edge-
to-face or edge-to-edge hydrogen bonding configurations. Such structures were 
eliminated. Unique structures were identified as those that exhibit clearly-defined π-
stacking interactions and for which the RMSD with all other structures exceeded 0.5 Å.  
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Figure VI-1. (a) Schematic representation of the nine starting positions of each ionizable 
side chain above the face of the aromatic side chain; (b) for each of these nine positions 
we considered six relative orienations of each ionizable side chain, for 54 total initial 
dimer geometries. (Asp interacting with Trp used as an example) 
 
 
For each unique dimer structure, the deprotonable hydrogen from the ionizable 
residue was then removed. The resulting deprotonated dimers were then optimized while 
Cβ for each monomer was held fixed, to mimic the restraining effect of the protein 
backbone. In some cases, the deprotonated complexes optimized to structures with very 
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small imaginary vibrational frequencies indicating that the structures are not true minima 
on the potential energy surface at this level of theory. However, these small imaginary 
frequencies resulted from small numerical errors in the DFT energies, coupled with the 
very flat nature of the associated potential energy surfaces, and do not impact the 
predicted pKa’s. 
For each unique complex, the deprotonation energy (ΔE) was defined as the 
difference in energy between the deprotonated dimer and the protonated dimer. From 
this, the absolute pKa can be computed via 
 𝑝𝐾𝑎 = −𝑙𝑜𝑔 (𝑒
−∆𝐸
𝑅𝑇 ) (VI-1) 
The change in pKa  upon complexation with an aromatic amino acid side chain, 
ΔpKa,was then computed from 
 ∆𝑝𝐾𝑎 = −𝑙𝑜𝑔 (𝑒
−∆∆𝐸
𝑅𝑇 ) (VI-2) 
where ΔΔE is the difference in deprotonation energies between the ionizable amino acid 
side chain complexed with an aromatic amino acid side chain and the corresponding 
isoliated ionizable amino acid side chain. That is, positive ΔpKa values signify that the 
complexation of the ionizable amino acid side chain with the aromatic amino caid 
hinders deprotonation of the ionizable side chain. 
For Lys and Arg, there are several possible protons that can be removed. For 
instance, upon complexation with another amino acid, the three protons of Lys are 
unique. We optimized the structure of the complexes resulting from removal of each of 
these protons, retaining the one that lead to the lowest-energy structure. Similarly, in the 
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case of Tyr
…
Tyr dimers, either one of the Tyr side chains can be deprotonated. In such 
dimers, we considered deprotonation of each Tyr side chain, and the reported ΔpKa 
value results from the deprotonation that lead to the lower-energy structure.  
For each ionizable residue we analyzed i) the conformational changes after 
deprotonation ii) the distribution and trend of pKa changes iii) the relationship between 
conformational changes and changes in pKa. Due to the nature of ionizable amino acids, 
hydrogen bonded complexes and charge-dipole complexes are inevitably formed before 
and after deprotonation. Thus the conformational changes and the resulting ΔpKa values 
for hydrogen bonding complexes are still worth investigating. Although we mainly focus 
on the effects of π-stacking and XH/π interactions between ionizable groups and 
aromatic groups, the effects of hydrogen bonding are discussed briefly. 
Finally, we note that even though DFT computations paired with continuum 
solvent models are not expected to yield quantitatively correct absolute pKa values, our 
interest here is on the change in pKa values upon complexation with different aromatic 
amino acid side chains. In this case, the expectation is that errors arising from the 
approximate treatment of solvation effects will largely cancel, leading to reliable relative 
pKa values. Similarly, entropic contributions are neglected (i.e. we consider energy 
differences, rather than free energies), based on the assumption that entropic 
contributions will largely cancel leading to reliable relative pKa values. 
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Results and Discussion 
 The predicted ΔpKa values for each ionizable amino acid side chain 
stacked with the aromatic residues Phe, Tyr, Trp, and His are displayed in Figure VI-2. 
In this plot, systems that maintain π-stacking configurations upon deprotonation are 
depicted with solid lines, whereas the dashed lines denote systems for which 
deprotonation leads to optimized structures with edge-to-face configurations. Overall, 
we predict significant changes in the pKa value of all seven ionizable amino acid side 
chains upon complexation. Notably, these predicted changes are at least as large as the 
standard deviation of measured pKa values for these groups in proteins (see Chart VI-1). 
The predicted ΔpKa values are mostly positive for all but Arg, for which the ΔpKa values 
are always negative. That is, for all but Arg, complexation with one of the aromatic 
amino acid side chains leads to a reduction in the acidity of these ionizable groups. More 
specific trends for individual ionizable amino acid side chains are discussed below. 
pKa Changes of Asp and Glu 
Aspartic and glutamic acids share many structural properties, and both bear a 
terminal carboxyl group that is deprotonated under physiological pH. Our computational 
results show that when Asp and Glu stack with aromatic amino acids, their pKa values 
only change in the positive direction (i.e. the protons become less acidic). Apparently, 
the aromatic amino acid side chains provide greater stabilization of the protonated Asp 
and Glu side chains than the deprotonated systems. This is consistent with the generally 
unfavorable interactions of anions with phenyl, phenol, indole, and imidazole rings. 
Overall, Asp exhibits fewer unique dimers across all four aromatic residues compared to 
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glutamic acid, presumably due to its smaller degree of conformational flexibility. 
Interestingly, for both Asp and Glu, the ΔpKa values show a bimodal distribution, with 
ΔpKa values either under 1 or above 2, suggesting that there are two families of 
interactions that lead to either large or relatively small changes in pKa. 
 
 
 
Figure VI-2. Distribution of ΔpKa values for each ionizable residue-aromatic residue 
dimer. Dimers involving hydrogen bonding are not included in the distribution. The 
dotted lines correspond to complexes that change to edge-to-face configurations upon 
deprotonation, while the solid lines are in π-stacking orientations.  
 
 
Although some of the complexes of Asp and Glu with the aromatic amino acid 
side chains showed significant conformational changes after deprotonation, there was no 
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correlation between the magnitude of ΔpKa and the extent of conformational change. 
Moreover, most of these complexes do not show any notable conformational changes 
after deprotonation.  
pKa Changes of Cys 
Cysteine is a small amino acid with an ionizable SH group that is protonated at 
physiological pH. Our results indicate the number of unique dimers of model Cys is 
much smaller compared to other ionizable residues; again, this is presumably due to the 
smaller size of Cys, which leads to less conformational flexibility. The range of ΔpKa 
values for Cys is also the smallest among all the seven ionizable groups, ranging from 0 
to 1.7 with a mean ΔpKa value close to 1 (Figure VI-2). All of the Cys complexes exhibit 
very small conformational changes upon deprotonation. 
pKa Changes of Tyr 
Tyrosine has an ionizable phenol group, which is neutral at physiological pH. 
Many of the complexes involving Tyr showed large conformational changes upon 
deprotonation, particularly for Tyr-Phe and Tyr-Tyr dimers. More precisely, after 
deprotonation, four of the eleven unique Tyr-Phe complexes adopt edge-to-face 
configurations. Similar conformational changes also occur to Tyr-Tyr dimers (see Figure 
VI-3), for which five out of 19 change from stacked configurations to edge-to-face 
complexes after removal of the acidic proton. For the Tyr-His dimers, on the other hand, 
nearly half of the complexes switch to edge-to-face configurations upon deprotonation. 
Moreover, there is a trend with regard to the tendency to engage in edge-to-face 
interactions and the ΔpKa values. First, edge-to-face interactions tend to lead to negative 
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ΔpKa values for Tyr stacked with each of the aromatic residues. Second, the complexes 
that switch to edge-to-face interactions typically lead to the largest pKa changes for Tyr-
Phe, Tyr-Trp and Tyr-Tyr complexes. The complexes that maintain π-stacking 
interactions upon deprotonation tended to exhibit much smaller ΔpKa values. 
 
 
 
Figure VI-3. Example of Tyr dimer that changes from a parallel-displaced configuration 
(a) to an edge-to-face configuration upon deprotonation (b).  
 
 
pKa Changes of His 
Histidine features an imidazole ring that has two ionizable NH groups, leading to 
two potential deprotonated states (deprotonation of the δ hydrogen or the ε hydrogen). 
Histidine is positively charged at physiological pH with ε protonation dominant. For the 
purpose of a more complete understanding of the effects of neighboring aromatic rings 
on different hydrogens, we considered the deprotonation of both δ and ε hydrogens when 
considering stacked dimers of histidine with aromatic amino acid residues. Removal of 
these different hydrogens has a great impact on both the dimer geometry and the 
predicted ΔpKa values. Overall, δ deprotonation leads to positive values of ΔpKa, while ε 
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deprotonation results in both positive and negative ΔpKa values. Deprotonated 
complexes featuring edge-to-face interactions occur much more frequently in His dimers 
compared to the other systems. Indeed, for His-Phe, His-Tyr and His-Trp dimers, edge-
to-face configurations predominate upon removal of the ε proton, nine out of 14 His-Phe 
dimers and six out of twelve His-Trp dimers switching from stacked configuration to 
edge-to-face configuration after ε deprotonation. Moreover, all of the negative ΔpKa 
values are due to complexes in which deprotonation leads to edge-to-face interactions. 
On the other hand, π-stacking configurations predominate after removal of the δ proton 
across all four aromatic residues; out of 52 δ-deprotonated dimers, 45 retain π-stacking 
interactions upon deprotonation. These systems that maintain π-stacking interactions 
always lead to positive ΔpKa values, with most stacked dimers leading to values from 
0.7 to 2.1 pKa units.  
pKa Changes of Lys and Arg 
Both Lys and Arg carry a positive charge at physiological pH, and both have 
long side chains with terminal ammonium and guanidinium groups, respectively. The 
most distinctive difference between Lys and Arg dimers is that arginine only exhibits 
negative ΔpKa values while nearly all of the Lys dimers show positive ΔpKa values. In 
both cases, deprotonation leads to relatively small conformational changes. Lys exhibits 
both CH/π and NH/π interactions in these complexes, which lead to differences in 
predicted ΔpKa values. For instance, complexes exhibiting NH/π interactions lead to the 
largest ΔpKa values for Lys complexed with each of the aromatic amino acid residues. 
Such NH/π interaction occurs frequently for the Lys-Phe, Lys-Tyr, and Lys-Trp dimers. 
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This is particularly true of the complexes with Trp, for which four out of seven unique 
dimers exhibit an NH/π interaction. Indeed, on average the ΔpKa value of Lys-Trp is 
higher than the other three mainly due to NH/π interactions in the former case. CH/π 
interactions, on the other hand, lead to more modest ΔpKa values of 0 to +2.  
Among all ionizable side chains, Arg is the only one that leads to negative ΔpKa 
values when complexed with aromatic residues. This mainly arises because Arg engages 
in stabilizing NH/π interactions upon deprotonation for Arg-Phe, Arg-Tyr and Arg-Trp 
dimers.  
The Effects of Hydrogen Bonding and Ion Dipole Interactions 
In Figure VI-3 and the associated discussion above, we considered only 
complexes in which the ionizable side chain engaged only in π-stacking interactions with 
the aromatic amino acid side chain, eliminating complexes with hydrogen-bonding 
interactions. In such cases, the ΔpKa values for all but Arg were almost all positive. 
Below, we consider the hydrogen-bonding complexes that were located. In these cases, 
Asp and Glu exhibit both positive and negative ΔpKa values. Overall, when the dimer 
changes from hydrogen bonded configuration to stacking configuration after 
deprotonation, the ΔpKa value is large and positive. If the dimer changes from stacking 
configuration to charge dipole configuration after deprotonation, ΔpKa was large and 
negative. Tyr dimers show relative large negative pKa changes when hydrogen bonding 
effects are involved. Some Lys-His dimers exhibit large positive ΔpKa values because 
they change from hydrogen-bonded conformation to stacked conformation after 
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deprotonation. For Arg-Tyr and Arg-His dimers, the few positive ΔpKa values and large 
negative ΔpKa values are also due to hydrogen bonding effects.  
 
 
 
Figure VI-4. Distribution of ΔpKa values for each ionizable residue-aromatic residue 
dimer with hydrogen bonded configurations. All Lys and arginine deprotonation states 
are included in this figure. 
 
 
Summary and Concluding Remarks 
The pKa values of ionizable amino acid side chains can be strongly influenced by 
their environment in proteins. Although changes in pKa for buried residues, relative to 
their intrinsic pKa of the isolated amino acid side chain, have long been understood to 
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arise from a combination of dehydration, Coulombic interactions, and hydrogen bonding 
interactions,
430,441-447
 little attention has been given to the role of other non-covalent 
interactions operative in these systems. In particular, π-stacking interactions have the 
potential to significantly alter the pKa of these ionizable groups. 
We predicted the change in pKa values for the seven ionizable amino acid side 
chains upon stacking with the aromatic amino acid side chains Phe, Tyr, Trp, and His. 
These π-stacking interactions can lead to significant changes in predicted pKa values 
compared to the isolated ionizable groups. Overall, the predicted changes in pKa values 
are mostly positive for all of the ionizable side chains except Arg. That is, the π-stacking 
of Asp, Glu, Cys, Tyr, His, or Lys with Phe, Tyr, Trp, or His typically leads to a 
decrease in the acidity of these ionizable side chains. With Arg, on the other hand, 
complexation with these aromatic side chains leads to an increase in the acidity of the 
guanidinium protons. The predicted change in pKa value is sensitive to the relative 
orientation of the complexed rings both before and after deprotonation. In particular, for 
Tyr and His dimers, negative pKa changes upon complexation with aromatic amino acid 
side chains were always accompanied by a change from a π-stacking to an edge-to-face 
configuration upon deprotonation. For His, deprotonation of tautomeric protons 
impacted both the dimer geometry and pKa change, with δ deprotonation leading to 
positive ΔpKa values and primarily stacked deprotonated dimers. When hydrogen-
bonding complexes were considered, there was a much broader range of predicted pKa 
changes, with both highly negative and positive values predicted for Asp, Glu, Tyr, Lys 
and Arg. 
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CHAPTER VII  
CONCLUSIONS 
 
In this research we first surveyed cation-π interactions involving alkali metal as a 
complement to our work on other non-covalent interactions in biological systems. 
Cation-π interactions were shown to be key non-covalent interactions in host-guest 
system, biology, materials science and chemical catalysis through spectroscopic and 
computational analyses. Furthermore, incorporating substituents and heteroatoms into 
aromatic rings systematically provides an effective means of altering the strength of 
cation-π interactions, and studying these effects will provide more thorough 
understanding of the nature of these interactions. 
We next explored non-covalent interactions involving π systems in four contexts: 
protein-DNA interactions, protein-ligand interactions, nucleic acid-ligand interactions, 
and interaction between amino acids. First, the role of non–covalent interactions in the 5’ 
binding site of the antibody ED-10 were examined. The marked selectivity of ED-10 for 
dTdC over dAdC was shown by MMGBSA and B97-D computations to result from 
differences in π-stacking and XH/π interactions between the nucleobase and a Trp 
residue in the binding site. Our computational results also predict that mutations of two 
key aromatic residues will severely impair in the selectivity for dTdC over dAdC, 
suggesting other antibodies without these key residues will not exhibit the same 5’-base 
selectivity as ED-10. Overall, both MMGBSA and B97-D data show that even though π-
stacking, CH/π, NH/π, and hydrogen bonding interactions all participate in the binding 
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of dinucleotides with ED-10, the strong selectivity for 5’-dT sequences is primarily a 
result of differences in aromatic interactions (XH/π and π-stacking interactions), not 
hydrogen-bonding. 
Next, π-stacking interactions between nitroarenes and model amino acid side 
chains, His, Phe, Trp, and Tyr,  were shown to be strong, ranging from –6.7 kcal mol–1 
(Phe with nitrobenzene) to –15.0 kcal mol–1 (Trp with 1,3,5-trinitrobenzene). Due to 
local, direct interactions between the nitro groups and substituents and heteroatoms in 
the amino acid side chains, the impact of multiple nitro groups were found to be non-
additive in complexes with His, Phe, Trp, and Tyr. Out of 216 crystal structures that 
contain nitroarenes in PDB, 191 contain aromatic amino acids within 5 Å of the 
nitroarene, and 65 well-defined π-stacking complexes were considered for computational 
analyses. π-stacking interactions between the nitroarene and aromatic amino acid side 
chains exhibit a broad range of strengths, with many contributing significantly to binding. 
Our results on the nitroarene binding mode and strength will help the identification of 
unrecognized nitroarene binding sites in proteins, and lead to more effective means of 
exploiting these interactions in biological applications. 
Next, stacking interactions of 9-methyladenine with 46 heterocycles 
representative of common fragments of drug-like molecules were examined, which show 
a broad range of interaction energies. Although larger heterocycles engage in generally 
stronger π-stacking interactions than their smaller analogs, the impact of relative 
orientations made some smaller rings also show highly favorable interactions. 
Heterocycles with NH groups exhibit strong π-stacking interactions with 9-
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methyladenine, presumably because of unconventional interactions between this NH 
group and the ring-nitrogens of adenine. Similarly, N
…
H3C interactions could be a 
second key factor that enhances π-stacking interactions of N-heterocycles with 9-
methyladenine. Since molecular dipoles only correlate with the binding strength of small 
heterocycles but not the larger, fused heterocycles, the preferred orientations and 
stacking interactions can be better explained by local, direct interactions between 
functional groups on the two interacting systems. 
Finally, our computational results indicate π-stacking interactions can lead to 
significant changes in predicted pKa for ionizable amino acid side chains. Stacking 
interactions of Asp, Glu, Cys, Tyr, His, or Lys with Phe, Tyr, Trp or His mostly lead to 
an increase in the predicted pKa compared to the isolated amino acids, while the pKa of 
arginine is always suppressed by such interactions. That is to say, except for arginine, 
ionizable residue-aromatic residue interactions tend to exhibit decreased acidity when 
complexed with aromatic amino acids. For Tyr and His dimers, the conformational 
changes before and after deprotonation has great impact on the predicted change in pKa 
value. Negative pKa changes were always associated with a change from π-stacking to 
edge-to-face configurations upon deprotonation. For His, the removal of different 
tautomeric protons had diverse effects, with δ deprotonation leading to positive changes 
in the pKa. 
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APPENDIX 
Table A-1. MMGBSA predicted pairwise binding enthalpies (kcal mol
–1) between the 3’ 
cytosine and key amino acid residues for four dinucleotides with ED-10. 
Res. dTdC dAdC dCdC dGdC 
HisL27D
a
 -5.8 -5.4 -5.5 -5.8 
TyrH97
a
 -4.0 -3.7 -4.2 -3.3 
TyrL32 -3.2 -3.6 -3.2 -3.4 
GlyH98 -2.5 -1.9 -2.5 -1.8 
SerH99 -2.1 -0.7 -2.2 -0.3 
AsnL28 -1.6 -1.3 -1.4 -1.2 
TrpH95 -1.1 -1.1 -1.1 -0.9 
GlyL91 -0.8 -1.9 -0.6 -2.2 
                                          a
This residue interacts with the back bone of 5’ cytosine. 
 
 
Table A-2. MMGBSA predicted binding enthalpies (kcal mol
–1
), relative to the native 
antigen 5’-dTdC, using single trjactory approach and multiple trajectory approach. 
 Single Traj Multiple Traj 
5’-dTdC 0.0 0.0 
5’-dAdC 8.7 15.5 
5’-dGdC 0.7 -1.5 
5’-dCdC 14.7 21.7 
           
   
Table A-3. Total interaction energy (kcal mol
–1) of the 5’-base with the 5’-binding site 
in the gas phase and in water using polarizable continuum model (PCM). 
 Gas Phase PCM 
5’-dTdC -38.8 -25.7 
5’-dAdC -32.7 -24.9 
5’-dGdC -22.8 -13.2 
5’-dCdC -45.2 -28.9 
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Figure A-1. Alignment of molecular dipole in stacked dimers of polar azines 18, 20, 21, 
23, 24, 26, and 27 with 9-methyladenine. Even though molecular dipole moments 
provide qualitatively correct predictions of preferred orientations in these cases, this 
does not hold for many of the other small heterocycles. 
 
